false2024Q3000178175512/31http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMemberP3YP3Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesbwin:segmentxbrli:pure00017817552024-01-012024-09-300001781755us-gaap:CommonClassAMember2024-10-290001781755us-gaap:CommonClassBMember2024-10-2900017817552024-09-3000017817552023-12-310001781755us-gaap:CommonClassAMember2024-09-300001781755us-gaap:CommonClassAMember2023-12-310001781755us-gaap:CommonClassBMember2024-09-300001781755us-gaap:CommonClassBMember2023-12-3100017817552024-07-012024-09-3000017817552023-07-012023-09-3000017817552023-01-012023-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-06-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-06-300001781755us-gaap:AdditionalPaidInCapitalMember2024-06-300001781755us-gaap:RetainedEarningsMember2024-06-300001781755us-gaap:NoncontrollingInterestMember2024-06-3000017817552024-06-300001781755bwin:RedeemableNoncontrollingInterestMember2024-06-300001781755us-gaap:RetainedEarningsMember2024-07-012024-09-300001781755us-gaap:NoncontrollingInterestMember2024-07-012024-09-300001781755bwin:RedeemableNoncontrollingInterestMember2024-07-012024-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-07-012024-09-300001781755us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-07-012024-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-09-300001781755us-gaap:AdditionalPaidInCapitalMember2024-09-300001781755us-gaap:RetainedEarningsMember2024-09-300001781755us-gaap:NoncontrollingInterestMember2024-09-300001781755bwin:RedeemableNoncontrollingInterestMember2024-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-12-310001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-12-310001781755us-gaap:AdditionalPaidInCapitalMember2023-12-310001781755us-gaap:RetainedEarningsMember2023-12-310001781755us-gaap:NoncontrollingInterestMember2023-12-310001781755bwin:RedeemableNoncontrollingInterestMember2023-12-310001781755us-gaap:RetainedEarningsMember2024-01-012024-09-300001781755us-gaap:NoncontrollingInterestMember2024-01-012024-09-300001781755bwin:RedeemableNoncontrollingInterestMember2024-01-012024-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2024-01-012024-09-300001781755us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-01-012024-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-06-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-06-300001781755us-gaap:AdditionalPaidInCapitalMember2023-06-300001781755us-gaap:RetainedEarningsMember2023-06-300001781755us-gaap:NoncontrollingInterestMember2023-06-3000017817552023-06-300001781755bwin:RedeemableNoncontrollingInterestMember2023-06-300001781755us-gaap:RetainedEarningsMember2023-07-012023-09-300001781755us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001781755bwin:RedeemableNoncontrollingInterestMember2023-07-012023-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-07-012023-09-300001781755us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-07-012023-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-09-300001781755us-gaap:AdditionalPaidInCapitalMember2023-09-300001781755us-gaap:RetainedEarningsMember2023-09-300001781755us-gaap:NoncontrollingInterestMember2023-09-3000017817552023-09-300001781755bwin:RedeemableNoncontrollingInterestMember2023-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-12-310001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-310001781755us-gaap:AdditionalPaidInCapitalMember2022-12-310001781755us-gaap:RetainedEarningsMember2022-12-310001781755us-gaap:ReceivablesFromStockholderMember2022-12-310001781755us-gaap:NoncontrollingInterestMember2022-12-3100017817552022-12-310001781755bwin:RedeemableNoncontrollingInterestMember2022-12-310001781755us-gaap:RetainedEarningsMember2023-01-012023-09-300001781755us-gaap:NoncontrollingInterestMember2023-01-012023-09-300001781755bwin:RedeemableNoncontrollingInterestMember2023-01-012023-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-01-012023-09-300001781755us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001781755us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-01-012023-09-300001781755us-gaap:ReceivablesFromStockholderMember2023-01-012023-09-300001781755us-gaap:ReceivablesFromStockholderMember2023-09-300001781755us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbwin:WholesaleBusinessMember2024-03-012024-03-010001781755us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberbwin:WholesaleBusinessMember2024-03-010001781755us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-07-012024-09-300001781755us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-07-012023-09-300001781755us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-01-012024-09-300001781755us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-01-012023-09-300001781755us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-09-300001781755us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310001781755bwin:CommissionRevenueMember2024-07-012024-09-300001781755bwin:CommissionRevenueMember2023-07-012023-09-300001781755bwin:CommissionRevenueMember2024-01-012024-09-300001781755bwin:CommissionRevenueMember2023-01-012023-09-300001781755bwin:ProfitSharingRevenueMember2024-07-012024-09-300001781755bwin:ProfitSharingRevenueMember2023-07-012023-09-300001781755bwin:ProfitSharingRevenueMember2024-01-012024-09-300001781755bwin:ProfitSharingRevenueMember2023-01-012023-09-300001781755bwin:ConsultingandServiceFeeRevenueMember2024-07-012024-09-300001781755bwin:ConsultingandServiceFeeRevenueMember2023-07-012023-09-300001781755bwin:ConsultingandServiceFeeRevenueMember2024-01-012024-09-300001781755bwin:ConsultingandServiceFeeRevenueMember2023-01-012023-09-300001781755bwin:PolicyFeeandInstallmentFeeRevenueMember2024-07-012024-09-300001781755bwin:PolicyFeeandInstallmentFeeRevenueMember2023-07-012023-09-300001781755bwin:PolicyFeeandInstallmentFeeRevenueMember2024-01-012024-09-300001781755bwin:PolicyFeeandInstallmentFeeRevenueMember2023-01-012023-09-300001781755us-gaap:OtherInsuranceProductLineMember2024-07-012024-09-300001781755us-gaap:OtherInsuranceProductLineMember2023-07-012023-09-300001781755us-gaap:OtherInsuranceProductLineMember2024-01-012024-09-300001781755us-gaap:OtherInsuranceProductLineMember2023-01-012023-09-300001781755bwin:JPMorganChaseBankNAMemberbwin:CreditAgreementAsAmendedThroughAmendmentNo.7September2023Member2023-12-310001781755bwin:JPMorganChaseBankNAMemberbwin:CreditAgreementAsAmendedThroughAmendmentNo.7September2023Memberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMember2023-12-310001781755bwin:JPMorganChaseBankNAMemberbwin:CreditAgreementAsAmendedThroughAmendmentNo.7September2023Memberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-12-310001781755bwin:JPMorganChaseBankNAMemberbwin:CreditAgreementAsAmendedThroughAmendmentNo.7September2023Memberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMember2023-12-312023-12-310001781755bwin:JPMorganChaseBankNAMemberbwin:CreditAgreementAsAmendedThroughAmendmentNo.7September2023Memberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMembersrt:MinimumMember2023-12-312023-12-310001781755bwin:JPMorganChaseBankNAMemberbwin:CreditAgreementAsAmendedThroughAmendmentNo.7September2023Memberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMembersrt:MaximumMember2023-12-312023-12-310001781755bwin:JPMorganChaseBankNAMemberbwin:CreditAgreementAsAmendedThroughAmendmentNo.7September2023Memberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MinimumMember2023-12-312023-12-310001781755bwin:JPMorganChaseBankNAMemberbwin:CreditAgreementAsAmendedThroughAmendmentNo.7September2023Memberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MaximumMember2023-12-312023-12-310001781755bwin:SeniorSecuredNotesDueMay2031Memberus-gaap:SeniorNotesMember2024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMember2024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-05-240001781755us-gaap:DebtInstrumentRedemptionPeriodOneMemberus-gaap:SeniorNotesMember2024-05-242024-05-240001781755us-gaap:DebtInstrumentRedemptionPeriodTwoMemberus-gaap:SeniorNotesMember2024-05-242024-05-240001781755us-gaap:DebtInstrumentRedemptionPeriodThreeMemberus-gaap:SeniorNotesMember2024-05-242024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMember2024-05-242024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMembersrt:MaximumMember2024-05-242024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMembersrt:MinimumMember2024-05-242024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMember2024-09-300001781755bwin:May2024CreditFacilityMemberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMember2024-09-302024-09-300001781755bwin:TotalNetLeverageReductionOneMemberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMember2024-05-240001781755bwin:TotalNetLeverageReductionTwoMemberus-gaap:SecuredDebtMemberus-gaap:MediumTermNotesMember2024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-05-242024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MinimumMember2024-05-242024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MaximumMember2024-05-242024-05-240001781755bwin:May2024CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300001781755bwin:May2024CreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-302024-09-300001781755bwin:TotalNetLeverageReductionOneMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-302024-09-300001781755bwin:TotalNetLeverageReductionTwoMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-302024-09-300001781755bwin:TotalNetLeverageReductionThreeMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-302024-09-300001781755bwin:May2024CreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300001781755bwin:A2024CreditAgreementMemberus-gaap:LineOfCreditMember2024-09-300001781755us-gaap:InterestRateCapMember2024-09-300001781755us-gaap:InterestRateCapMember2023-12-310001781755us-gaap:InterestRateCapMember2024-07-012024-09-300001781755us-gaap:InterestRateCapMember2024-01-012024-09-300001781755us-gaap:InterestRateCapMember2023-07-012023-09-300001781755us-gaap:InterestRateCapMember2023-01-012023-09-300001781755us-gaap:RelatedPartyMember2023-12-310001781755us-gaap:RelatedPartyMemberbwin:EmeraldBayRiskSolutionsLLCMemberbwin:LoanMadeToEmeraldBayMember2023-12-310001781755us-gaap:RelatedPartyMemberbwin:EmeraldBayRiskSolutionsLLCMember2024-09-300001781755us-gaap:RelatedPartyMemberbwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMemberbwin:BrokerServicesMember2024-07-012024-09-300001781755us-gaap:RelatedPartyMemberbwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMemberbwin:BrokerServicesMember2023-07-012023-09-300001781755us-gaap:RelatedPartyMemberbwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMemberbwin:BrokerServicesMember2024-01-012024-09-300001781755us-gaap:RelatedPartyMemberbwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMemberbwin:BrokerServicesMember2023-01-012023-09-300001781755us-gaap:RelatedPartyMemberbwin:EntitiesInWhichMemberOfBoardOfDirectorsHasMaterialInterestMemberbwin:BrokerServicesMember2024-07-012024-09-300001781755us-gaap:RelatedPartyMemberbwin:EntitiesInWhichMemberOfBoardOfDirectorsHasMaterialInterestMemberbwin:BrokerServicesMember2023-07-012023-09-300001781755us-gaap:RelatedPartyMemberbwin:EntitiesInWhichMemberOfBoardOfDirectorsHasMaterialInterestMemberbwin:BrokerServicesMember2024-01-012024-09-300001781755us-gaap:RelatedPartyMemberbwin:EntitiesInWhichMemberOfBoardOfDirectorsHasMaterialInterestMemberbwin:BrokerServicesMember2023-01-012023-09-300001781755bwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMemberus-gaap:RelatedPartyMember2023-07-012023-09-300001781755bwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMemberus-gaap:RelatedPartyMember2024-07-012024-09-300001781755bwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMemberus-gaap:RelatedPartyMember2024-01-012024-09-300001781755bwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMemberus-gaap:RelatedPartyMember2023-01-012023-09-300001781755us-gaap:RelatedPartyMemberbwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMember2024-09-300001781755us-gaap:RelatedPartyMemberbwin:HoldingCompanyOfTheVillagesIncAndAffiliatedEntitiesMember2023-12-310001781755us-gaap:RelatedPartyMemberbwin:OtherPartiesExcludingHoldingCompanyOfTheVillagesIncMember2024-07-012024-09-300001781755us-gaap:RelatedPartyMemberbwin:OtherPartiesExcludingHoldingCompanyOfTheVillagesIncMember2023-07-012023-09-300001781755us-gaap:RelatedPartyMemberbwin:OtherPartiesExcludingHoldingCompanyOfTheVillagesIncMember2024-01-012024-09-300001781755us-gaap:RelatedPartyMemberbwin:OtherPartiesExcludingHoldingCompanyOfTheVillagesIncMember2023-01-012023-09-300001781755us-gaap:RelatedPartyMemberbwin:OtherPartiesExcludingHoldingCompanyOfTheVillagesIncMember2024-09-300001781755us-gaap:RelatedPartyMemberbwin:OtherPartiesExcludingHoldingCompanyOfTheVillagesIncMember2023-12-310001781755bwin:BRPGroupInc.OmnibusIncentivePlanMemberus-gaap:CommonClassAMember2024-09-300001781755bwin:BRPGroupIncPartnershipInducementAwardPlanMemberus-gaap:CommonClassAMember2024-09-300001781755bwin:BRPGroupIncOmnibusIncentiveAndPartnershipInducementAwardPlansMemberus-gaap:PerformanceSharesMemberbwin:ShareBasedPaymentArrangementCliffVestingMember2024-01-012024-09-300001781755bwin:BRPGroupIncOmnibusIncentiveAndPartnershipInducementAwardPlansMemberus-gaap:RestrictedStockMemberbwin:ShareBasedPaymentArrangementCliffVestingMembersrt:MinimumMember2024-01-012024-09-300001781755bwin:BRPGroupIncOmnibusIncentiveAndPartnershipInducementAwardPlansMemberus-gaap:RestrictedStockMemberbwin:ShareBasedPaymentArrangementCliffVestingMembersrt:MaximumMember2024-01-012024-09-300001781755bwin:BRPGroupIncOmnibusIncentiveAndPartnershipInducementAwardPlansMemberus-gaap:RestrictedStockMemberbwin:ShareBasedPaymentArrangementRatableVestingMembersrt:MinimumMember2024-01-012024-09-300001781755bwin:BRPGroupIncOmnibusIncentiveAndPartnershipInducementAwardPlansMemberus-gaap:RestrictedStockMemberbwin:ShareBasedPaymentArrangementRatableVestingMembersrt:MaximumMember2024-01-012024-09-300001781755bwin:RestrictedStockRSAsAndRestrictedStockUnitsRSUsMember2024-07-012024-09-300001781755bwin:RestrictedStockRSAsAndRestrictedStockUnitsRSUsMember2023-07-012023-09-300001781755bwin:RestrictedStockRSAsAndRestrictedStockUnitsRSUsMember2024-01-012024-09-300001781755bwin:RestrictedStockRSAsAndRestrictedStockUnitsRSUsMember2023-01-012023-09-300001781755us-gaap:EquityUnitPurchaseAgreementsMember2024-07-012024-09-300001781755us-gaap:EquityUnitPurchaseAgreementsMember2023-07-012023-09-300001781755us-gaap:EquityUnitPurchaseAgreementsMember2024-01-012024-09-300001781755us-gaap:EquityUnitPurchaseAgreementsMember2023-01-012023-09-300001781755us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001781755us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001781755us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001781755us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001781755us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001781755us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001781755us-gaap:MeasurementInputLongTermRevenueGrowthRateMembersrt:MinimumMember2024-09-300001781755us-gaap:MeasurementInputLongTermRevenueGrowthRateMembersrt:MaximumMember2024-09-300001781755us-gaap:MeasurementInputLongTermRevenueGrowthRateMembersrt:MinimumMember2023-12-310001781755us-gaap:MeasurementInputLongTermRevenueGrowthRateMembersrt:MaximumMember2023-12-310001781755us-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2023-12-310001781755us-gaap:MeasurementInputDiscountRateMembersrt:MaximumMember2023-12-310001781755bwin:ContingentEarnoutLiabilitiesMember2024-06-300001781755bwin:ContingentEarnoutLiabilitiesMember2023-06-300001781755bwin:ContingentEarnoutLiabilitiesMember2023-12-310001781755bwin:ContingentEarnoutLiabilitiesMember2022-12-310001781755bwin:ContingentEarnoutLiabilitiesMember2024-07-012024-09-300001781755bwin:ContingentEarnoutLiabilitiesMember2023-07-012023-09-300001781755bwin:ContingentEarnoutLiabilitiesMember2024-01-012024-09-300001781755bwin:ContingentEarnoutLiabilitiesMember2023-01-012023-09-300001781755bwin:ContingentEarnoutLiabilitiesMember2024-09-300001781755bwin:ContingentEarnoutLiabilitiesMember2023-09-300001781755us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300001781755us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300001781755us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001781755us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001781755bwin:InsuranceAdvisorySolutionsMember2024-07-012024-09-300001781755bwin:UnderwritingCapacityTechnologySolutionsMember2024-07-012024-09-300001781755bwin:MainstreetInsuranceSolutionsMember2024-07-012024-09-300001781755us-gaap:CorporateAndOtherMember2024-07-012024-09-300001781755bwin:InsuranceAdvisorySolutionsMember2023-07-012023-09-300001781755bwin:UnderwritingCapacityTechnologySolutionsMember2023-07-012023-09-300001781755bwin:MainstreetInsuranceSolutionsMember2023-07-012023-09-300001781755us-gaap:CorporateAndOtherMember2023-07-012023-09-300001781755bwin:InsuranceAdvisorySolutionsMember2024-01-012024-09-300001781755bwin:UnderwritingCapacityTechnologySolutionsMember2024-01-012024-09-300001781755bwin:MainstreetInsuranceSolutionsMember2024-01-012024-09-300001781755us-gaap:CorporateAndOtherMember2024-01-012024-09-300001781755bwin:InsuranceAdvisorySolutionsMember2023-01-012023-09-300001781755bwin:UnderwritingCapacityTechnologySolutionsMember2023-01-012023-09-300001781755bwin:MainstreetInsuranceSolutionsMember2023-01-012023-09-300001781755us-gaap:CorporateAndOtherMember2023-01-012023-09-300001781755bwin:SameOperatingGroupMemberus-gaap:IntersegmentEliminationMemberbwin:UnderwritingCapacityTechnologySolutionsMember2024-07-012024-09-300001781755bwin:SameOperatingGroupMemberus-gaap:IntersegmentEliminationMemberbwin:UnderwritingCapacityTechnologySolutionsMember2024-01-012024-09-300001781755bwin:OtherOperatingGroupMemberus-gaap:IntersegmentEliminationMemberbwin:UnderwritingCapacityTechnologySolutionsMember2024-07-012024-09-300001781755bwin:OtherOperatingGroupMemberus-gaap:IntersegmentEliminationMemberbwin:UnderwritingCapacityTechnologySolutionsMember2024-01-012024-09-300001781755us-gaap:IntersegmentEliminationMemberbwin:MainstreetInsuranceSolutionsMember2024-07-012024-09-300001781755us-gaap:IntersegmentEliminationMemberbwin:MainstreetInsuranceSolutionsMember2024-01-012024-09-300001781755bwin:SameOperatingGroupMemberus-gaap:IntersegmentEliminationMemberbwin:UnderwritingCapacityTechnologySolutionsMember2023-07-012023-09-300001781755bwin:SameOperatingGroupMemberus-gaap:IntersegmentEliminationMemberbwin:UnderwritingCapacityTechnologySolutionsMember2023-01-012023-09-300001781755bwin:OtherOperatingGroupMemberus-gaap:IntersegmentEliminationMemberbwin:UnderwritingCapacityTechnologySolutionsMember2023-07-012023-09-300001781755bwin:OtherOperatingGroupMemberus-gaap:IntersegmentEliminationMemberbwin:UnderwritingCapacityTechnologySolutionsMember2023-01-012023-09-300001781755us-gaap:IntersegmentEliminationMemberbwin:MainstreetInsuranceSolutionsMember2023-07-012023-09-300001781755us-gaap:IntersegmentEliminationMemberbwin:MainstreetInsuranceSolutionsMember2023-01-012023-09-300001781755bwin:InsuranceAdvisorySolutionsMember2024-09-300001781755bwin:UnderwritingCapacityTechnologySolutionsMember2024-09-300001781755bwin:MainstreetInsuranceSolutionsMember2024-09-300001781755us-gaap:CorporateAndOtherMember2024-09-300001781755bwin:InsuranceAdvisorySolutionsMember2023-12-310001781755bwin:UnderwritingCapacityTechnologySolutionsMember2023-12-310001781755bwin:MainstreetInsuranceSolutionsMember2023-12-310001781755us-gaap:CorporateAndOtherMember2023-12-31

美國
證券交易委員會
華盛頓特區20549
_________________________________________
表格 10-Q
_________________________________________
(標記一個)
x根據1934年證券交易法第13或15(d)條的季度報告
截至2024年6月30日季度結束 2024年9月30日
o
根據1934年證券交易法第13或15(d)條款的過渡報告。
為了從________到________的過渡期
委員會檔案編號: 001-39095
_________________________________________
鮑德溫保險集團有限公司。
(依憑章程所載的完整登記名稱)
_________________________________________
特拉華州
TBG logo std - full color.jpg
61-1937225
(依據所在地或其他管轄區)(國稅局雇主識別號碼)
的註冊地或組織地點)識別號碼)
4211 W. Boy Scout Blvd., 800號套房, Tampa, 佛羅里達 33607
(主要行政辦公室的地址)(郵政編碼)
(866) 279-0698
(註冊人電話號碼,包括區號)
不適用
(如自上次報告以來更改,則列出前名稱、前地址和前財政年度)
根據法案第12(b)條規定註冊的證券:
每種類別的名稱交易標的(s)每個註冊交易所的名稱
$0.01每股的A級普通股BWIN納斯達克全球貨幣選擇市場
_________________________________________
標示勾選是否該登記者已在過去12個月(或該登記者應該提交這些報告的更短期間)內按照1934年證券交易法第13條或第15(d)條的規定提交了所需提交的所有報告,並且(2)該登記者在過去90天內一直受到這些提交要求的規定。 xo
請勾選表明,公司是否在過去12個月內(或公司需提交該等檔案的較短期間)依據《S-T條例》第405條規定提交每個互動數據檔案。 x o
請勾選該公司是否為大型加速彙繳申報人、加速申報人、非加速申報人、較小的報告公司或新興成長公司。請參見交易所法案規則120億2中「大型加速彙繳申報人」、「加速申報人」、「較小的報告公司」和「新興成長公司」的定義。
大型加速歸檔人x加速歸檔人o
非加速歸檔人o小型報告公司o
新興成長型企業o
若為新興成長型公司,請勾選該選項以指示公司選擇不使用依據第13(a)條的《交易所法》提供的任何新的或修訂的財務會計標準的延長過渡期進行遵循。 o
請在選框內打勾,表示公司是否為空殼公司(根據交易所法規第12億2條定義)。是 o  x
截至2024年10月29日,有 67,569,242 現有A類普通股股份外加 50,013,563 現有B類普通股股份外加.



THE BALDWIN INSURANCE GROUP, INC.
指数
頁面




Note Regarding Forward-Looking Statements
我們在本報告中作出了一些聲明,包括在第I部分,第2項中討論的事項。管理層對財務狀況和營運結果的討論,第II部分,項目1中的法律訴訟,第II部分,項目1A中的風險因素以及本報告的其他部分中的內容,這些內容是前瞻性陳述。在某些情況下,您可以通過前瞻性詞語,如“可能”,“可能”,“將”,“應該”,“預期”,“計劃”,“預期”,“相信”,“估計”,“預測”,“潛在性”或“持續”,以及這些術語的否定形式和其他可比術語來識別這些聲明。這些前瞻性陳述可能包括對我們未來財務表現的預測,我們預期的增長策略以及我們業務中預期的趨勢。有一些重要因素可能導致我們的實際結果,活動水平,表現或成就與前瞻性陳述所表達或暗示的結果,活動水平,表現或成就存在重大差異。您應具體考慮我們在年度報告第I部分中概略列出的眾多風險,即在2023年12月31日結束的Form 10-k提交給美國證券交易委員會的2024年2月28日提交的第1A項中的風險因素。
雖然我們認為前瞻性陳述中所反映的期望是合理的,但我們無法保證未來結果、活動水平、表現或成就。此外,無論是我們還是任何其他人都不對任何這些前瞻性陳述的準確性和完整性承擔責任。我們不負有更新這些前瞻性陳述的義務,在本報告日期之後使我們先前的陳述符合實際結果或修訂的期望,除非法律要求。




常用的定義術語
除非上下文顯示或要求其他,否則本第10-Q季度報告中以下術語具有以下含義:
2019股東協議
鮑德溫與鮑德溫控股公司LLC單元持有人之間於2019年10月28日簽訂的股東協議
2024信貸協議2024年5月24日簽訂的修訂後的信貸協議,作為借款人的鮑德溫控股公司、行政代理人摩根大通銀行、保證人和貸款人之間的修訂協定的附件I
2024年信貸設施根據2024信貸協議建立的2024年循環設施和2024年定期貸款
2024年循環設施
我們根據2024信貸設施的循環信貸,承諾總額為60000萬美元,到期日為2029年5月24日
2024長期貸款
我們在2024年信貸工具下的長期貸款,本金金額為$84000萬,到期日為2031年5月24日
修訂後的有限責任公司協議Baldwin Holdings的第三份修正及重訂有限責任公司協議,經修訂
API應用程式介面
業務書我們代表客戶簽訂的保險保單
bps基點
鮑德溫控股Baldwin保險集團控股有限責任公司(前身為Baldwin Risk Partners有限責任公司),我們的營運公司,是Baldwin的子公司
BaldwinBaldwin保險集團公司(前身為brp group,Inc.),我們的母公司,與其合併子公司(除非上下文要求另外),包括Baldwin Holdings及其合併子公司和聯屬公司
客戶我們的被保險人
同事我們的員工
證券交易所法案1934年修訂後的證券交易法
GAAP美國公認會計原則
保險公司合作夥伴與我們有合約關係的保險公司
摩根大通信貸協議信貸協議,於2020年10月14日生效,由借款人鮑德溫控股公司、摩根大通銀行股份有限公司擔任行政代理人,擔保方、貸款方和發行貸款方共同簽署,並已由2021年5月7日的第1號修正案、2021年6月2日的第2號信貸協議修正案、2021年8月6日的第3號信貸協議修正案、2021年12月16日的第4號信貸協議修正案、2022年3月28日的第5號信貸協議修正案、2023年6月27日的第6號信貸協議修正案和2023年9月15日的第7號信貸協議修正案修正
有限責任公司單位鮑德溫控股公司的持有權益
MGAManaging General Agent
微星我們的MGA平台,又稱未來MGA
營運組我們的可報告領域
合夥人我們已收購的公司,或在資產收購的情況下,製造商
合夥關係公司進行的策略性收購
Pre-IPO有限責任公司成員Trevor Baldwin,我們的首席執行官;Lowry Baldwin,我們的主席;BIGH,LLC,由Lowry Baldwin控制的實體;Elizabeth Krystyn,我們的其中一位創始人;Laura Sherman,我們的其中一位創始人;Daniel Galbraith,The Baldwin Group總裁暨零售券商業務CEO;Brad Hale,我們的財務長;及The Villages景順股份公司,以及特定其他歷史權益持有人,包括我們已收購或製造商的公司的股東
QBEQBE保險公司及其聯屬公司



QBE計劃管理協議
與QBE Holdings, Inc.的子公司簽訂的協議,根據該協議,我們的MSI業務向QBE保險公司提供計劃管理業務,涉及我們從建築商處收到的房主保單組合中由QBE保險公司子公司承保的部分
風險顧問我們的製作人
美國證券交易委員會美國證券交易委員會
證券法1933年證券法,經修訂
優先擔保票據
7.125%擁有總本金額為60000萬美元的2021年5月15日到期的優先有擔保票據
SOFR隔夜拆款利率
稅收協議Baldwin與2019年10月28日進入Baldwin Holdings的LLC單位持有人之間的稅收協議
WestwoodWestwood保險中介,一家2022年的合作夥伴
批發業務我們專營的批發經紀業務於2024年3月1日出售



第一部分. 財務資訊
項目 1. 基本報表
THE BALDWIN INSURANCE GROUP, INC.
縮短的合併財務報表
(未經查核)
(以千為單位,每股數據除外)2024年9月30日2023年12月31日
資產
流動資產:
現金及現金等價物$181,759 $116,209 
限制性現金162,957 104,824 
應收保險費、佣金及費用,淨額656,111 627,791 
預付費用及其他流動資產13,454 12,730 
待售資產 64,351 
全部流動資產1,014,281 925,905 
物業及設備,扣除折舊後淨值21,263 22,713 
租賃資產74,960 85,473 
其他資產47,356 38,134 
無形資產,扣除累計攤銷968,811 1,017,343 
商譽1,412,369 1,412,369 
資產總額$3,539,040 $3,501,937 
負債、次級股本和股東 權益
流動負債:
應付給保險公司的保費$589,157 $555,569 
應付的生產商佣金71,179 64,304 
應計費用及其他流動負債164,302 152,954 
相關方應付票據5,635 1,525 
附帶的賺取條款負債流動部分201,281 215,157 
待售負債 43,931 
流動負債合計1,031,554 1,033,440 
循環信用額度 341,000 
長期負債,不含流動部分1,399,010 968,183 
附帶的賺取條款負債,減少流動部分2,509 61,310 
營業租賃負債,扣除當前部分69,235 78,999 
其他負債123 123 
總負債2,502,431 2,483,055 
承諾和或有事項(註13)
中級股權:
可贖回非控制權益375 394 
股東權益:
A類普通股,面值 $0.01300,000,000 授權股份為 67,536,34764,133,950 於2024年9月30日和2023年12月31日分別發行和流通的股份
675 641 
普通B股,面值$0.0001100,000,000 授權股份為 50,013,56352,422,494 於2024年9月30日和2023年12月31日分別發行和流通的股份
5 5 
資本公積額額外增資785,931 746,671 
累積虧損(191,261)(186,905)
歸屬於鮑德溫的股東權益總額595,350 560,412 
非控制權益440,884 458,076 
股東權益總額1,036,234 1,018,488 
參見附註未經審計的簡明合併財務報表$3,539,040 $3,501,937 
見附帶的基本報表附註。
6


THE BALDWIN INSURANCE GROUP, INC.
綜合損益簡明綜合損益表
(未經查核)
三個月內
截至9月30日
為期九個月之總結
截至9月30日
(以千為單位,每股數據除外)2024202320242023
收入:
佣金和費用$335,210 $304,232 $1,050,409 $929,306 
投資收益3,728 2,038 8,736 4,601 
總收益338,938 306,270 1,059,145 933,907 
營業費用:
佣金、員工薪酬和福利247,189 220,469 753,596 676,659 
其他營業費用48,839 47,165 141,198 141,254 
攤銷費用26,899 23,183 76,334 69,505 
條件性考慮變動的公允價值(952)13,914 17,276 55,065 
折舊費用1,557 1,453 4,619 4,250 
營業費用總計323,532 306,184 993,023 946,733 
營業利益(損失)15,406 86 66,122 (12,826)
其他收入(費用):
利息費用,淨額(31,329)(30,580)(94,203)(87,600)
處分收益1,809  38,953  
償還和修改債務的虧損(389) (15,068) 
其他收入(費用),淨額28 (1,351)105 (193)
總其他費用,淨額(29,881)(31,931)(70,213)(87,793)
收入稅前虧損
(14,475)(31,845)(4,091)(100,619)
所得稅支出 161 2,151 904 
淨損失
(14,475)(32,006)(6,242)(101,523)
減:歸屬於非控制權益的凈虧損
(6,098)(14,377)(1,886)(45,865)
巴爾德溯屬淨虧損
$(8,377)$(17,629)$(4,356)$(55,658)
全面損失
$(14,475)$(32,006)$(6,242)$(101,523)
歸屬於非控股權益的綜合損失
(6,098)(14,377)(1,886)(45,865)
巴爾德溯屬綜合虧損
(8,377)(17,629)(4,356)(55,658)
每股基本和稀释的亏损
$(0.13)$(0.29)$(0.07)$(0.93)
A類普通股基本和稀釋加權平均已發行股份64,011,51560,549,08063,001,12559,791,435







請參閱附註的基本財務報表。
7


鮑德溫保險集團股份有限公司。
壓縮的股東權益和中間層權益綜合報表
(未經審計)
截至2024年9月30日三個月
股東。我們的修訂後的公司章程還指定了有關股東通知的表單和內容的某些要求。這些規定可能會阻止我們的股東在我們的股東年會上提出問題或在我們的股東年會上對董事進行提名。 權益
夾層權益
A類普通股B類普通股股本外溢價累計赤字非控制權益總計可贖回的非控制權益
(以千爲單位,除股票數據外) 股份金額股份金額
2024年6月30日餘額66,544,590$665 50,943,644$5 $773,109 $(182,884)$452,364 $1,043,259 $286 
— — — — — (8,377)(6,187)(14,564)89 
以股份爲基礎的報酬,扣除抵消61,6761 — — 4,323 — 3,215 7,539 — 
贖回B類普通股930,081 9 (930,081)— 8,499 — (8,508) — 
2024年9月30日的餘額67,536,347$675 50,013,563$5 $785,931 $(191,261)$440,884 $1,036,234 $375 

2024年9月30日結束的九個月
股東權益夾層權益
A類普通股B類普通股股本外溢價累計赤字非控制權益總計可贖回的非控制權益
(以千爲單位,除股票數據外) 股份金額股份金額
2023年12月31日結餘爲64,133,950$641 52,422,494$5 $746,671 $(186,905)$458,076 $1,018,488 $394 
— — — — — (4,356)(2,131)(6,487)245 
以股份爲基礎的報酬,扣除抵消993,46610 — — 19,878 — 15,421 35,309 — 
贖回b類普通股2,408,931 24 (2,408,931)— 19,382 — (19,406) — 
向Baldwin Holdings LLC成員分配稅款— — — — — — (11,076)(11,076)— 
向可變利益實體分配— — — — — — — — (264)
2024年9月30日的餘額67,536,347$675 50,013,563$5 $785,931 $(191,261)$440,884 $1,036,234 $375 






















請參閱附註的基本財務報表。
8


鮑德溫保險集團股份有限公司。
壓縮的合併股東權益和夾層權益表(續)
(未經審計)
截至2023年9月30日的三個月
股東 股權
夾層股權
A 類普通股B 類普通股額外的實收資本累計赤字非控股權益總計可贖回的非控股權益
(以千計,共享數據除外)股票金額股票金額
截至 2023 年 6 月 30 日的餘額63,696,680$637 53,024,504$5 $732,673 $(134,793)$498,245 $1,096,767 $495 
淨收益(虧損)— — — — — (17,629)(14,459)(32,088)82 
扣除沒收後的股份薪酬(5,777)— — — 4,898 — 4,017 8,915 — 
贖回 b 類普通股538,410 5 (538,410)— 4,982 — (4,987) — 
對寶德威控股有限責任公司成員的稅收分配— — — — — — (47)(47)— 
對可變利息實體的分配— — — — — — — — (244)
截至 2023 年 9 月 30 日的餘額64,229,313$642 52,486,094$5 $742,553 $(152,422)$482,769 $1,073,547 $333 

截止2023年9月30日止九個月
股東。我們的修訂後的公司章程還指定了有關股東通知的表單和內容的某些要求。這些規定可能會阻止我們的股東在我們的股東年會上提出問題或在我們的股東年會上對董事進行提名。 權益
夾層權益
A類普通股B類普通股股本外溢價累計赤字股東應收賬款非控制權益總計可贖回的非控制權益
(以千爲單位,除股票數據外) 股份金額股份金額
2022年12月31日結存餘額61,447,368$614 54,504,918$5 $704,291 $(96,764)$(42)$531,448 $1,139,552 $487 
— — — — — (55,658)— (46,096)(101,754)231 
以股份爲基礎的報酬,扣除抵消763,121 8 — — 19,517 — — 16,590 36,115 — 
贖回b類普通股2,018,824 20 (2,018,824)— 18,745 — — (18,765) — 
向Baldwin Holdings LLC成員分配稅款— — — — — — — (408)(408)— 
償還股東應收票據— — — — — — 42 — 42 — 
向可變利益實體分配— — — — — — — — — (385)
2023年9月30日結餘64,229,313$642 52,486,094$5 $742,553 $(152,422)$ $482,769 $1,073,547 $333 














請參閱附註的基本財務報表。
9


鮑德溫保險集團股份有限公司。
簡明的綜合現金流量表
(未經審計)
九個月期間
截至9月30日,
(以千爲單位)20242023
經營活動現金流量:
淨損失$(6,242)$(101,523)
調整使淨損失轉化爲經營活動產生的現金流量:
折舊和攤銷
80,953 73,755 
應計可變對價公允價值變動17,276 55,065 
基於股份的報酬支出46,764 46,637 
超出購買價格預提款項的待定業績補償支付(21,145)(22,639)
出售利得(38,953) 
推遲融資成本的攤銷4,419 3,577 
債務清償損失1,034  
利率上限損失244 489 
其他虧損346 797 
經營性資產和負債變動:
應收保險費、佣金及手續費淨額(27,777)(63,367)
預付費用和其他流動資產(7,980)(6,294)
使用權資產12,562 7,671 
應付賬款、應計費用及其他流動負債35,395 32,793 
經營租賃負債(11,188)(4,162)
經營活動產生的現金流量淨額85,708 22,799 
投資活動現金流量:
處置收益淨額,扣除轉移現金56,977  
資本支出(28,897)(14,157)
對業務投資和貸款(3,703)(673)
從關聯方貸款償還所得款項1,500  
支付資產收購的現金考慮(268)(2,118)
投資活動產生的淨現金流量25,609 (16,948)
籌集資金的現金流量:
支付股票價格應計金額直至潛在收益獎勵金的金額(64,698)(26,808)
循環信貸額度的收益
95,000 88,000 
可循環授信額度的付款(436,000)(269,000)
長期債務再融資所得1,440,000 170,000 
與熄滅和修改長期債務相關的支付(996,177) 
開多期債償付款
(4,661)(6,815)
延期融資成本支付(17,988)(4,447)
利率上限結算所得2,300 7,893 
向Baldwin Holdings LLC成員分配稅款(11,076)(408)
向可變利益實體分配(264)(385)
股東應收款項償還款額 42 
籌集資金的淨現金流量6,436 (41,928)
現金及現金等價物和受限制的現金淨增(減)額117,753 (36,077)
期初的現金及現金等價物和受限制的現金
226,963 230,471 
期末的現金及現金等價物和受限制的現金$344,716 $194,394 
請參閱附註的基本財務報表。
10


鮑德溫保險集團股份有限公司。
簡明合併現金流量表(續)
(未經審計)
九個月期間
截至9月30日結束
(以千爲單位)20242023
補充現金流量信息表:
期間支付的利息$73,417 $77,455 
期間支付的所得稅2,717 1,208 
披露非現金投資和融資活動:
將計件盈利責任轉爲關聯方應付票據$5,636 $ 
在交換運營租賃負債獲得的使用權資產2,111 4,391 
已發生但未付的資本支出1,821 699 
使用權資產通過租賃修改和重新評估增加(減少)(99)697 
在資產收購中確認的計提業績分成負債 723 
發行的非現金債務費用發生 245 
商譽減少是由於對往年業務組合的計量期調整引起的 (211)









































請參閱附註的基本財務報表。
11


鮑德溫保險集團股份有限公司。
簡明合併財務報表註釋
(未經審計)
1. 業務和報告基礎
The Baldwin 保險 集團股份有限公司於特拉華州註冊成立於 2019年7月1日 作爲 brp group 公司,於2024年5月2日更名爲The Baldwin 保險 集團股份有限公司。
The Baldwin Insurance Group, Inc.是一家控股公司,也是The Baldwin Insurance Group Holdings, LLC(原Baldwin Risk Partners, LLC)的唯一管理成員("Baldwin Holdings"),其唯一實質性資產是對Baldwin Holdings的所有權,通過該公司進行了並正在進行所有業務。在這些簡明綜合財務報表中,除非上下文另有要求,"Baldwin"和"公司"一詞指的是The Baldwin Insurance Group, Inc.,以及其合併子公司,包括Baldwin Holdings及其合併子公司和關聯公司。
Baldwin是一家多元化保險代理和服務機構,向美國各地的客戶推銷保險產品和服務。該公司的業務很大一部分集中在美國東南部,還有其他幾個區域聚集地。Baldwin及其子公司通過經營部門運營 彙報分部("經營部門")包括保險諮詢解決方案、承保、能力與技術解決方案和Mainstreet保險解決方案,詳情請參閱第14注。
合併原則
綜合財務報表包括巴爾德溫及其全資子公司的帳戶。所有公司間交易和餘額在合併時已被消除。
作爲Baldwin Holdings的唯一經理,Baldwin經營和控制Baldwin Holdings的所有業務和事務,並擁有對Baldwin Holdings的獨家表決權利,並控制Baldwin Holdings的管理。因此,Baldwin在其合併基本報表中合併Baldwin Holdings,導致與公司合併基本報表中Baldwin Holdings成員持有的Baldwin Holdings的成員權益相關的非控股權益。
公司根據會計準則規範(「ASC」)主題810編制了這些簡明的合併基本報表, 合併。(主題810)。 主題810要求,如果企業是可變利益實體的主要受益人,則可變利益實體的資產、負債和經營結果應包括在企業的合併基本報表中。 公司已將某些實體確認爲可變利益實體,其中公司是主要受益人,並已將這些實體的帳戶包括在合併基本報表中。 有關公司可變利益實體的更多信息,請參考附註3。
主題810還要求在公司的基本報表中將非控制權益的權益報告在緊縮的合併資產負債表中的總權益內。某些可贖回的非控股權益被報告在緊縮的合併資產負債表中作爲中級權益。主題810還要求在合併財務報表中以合併金額報告營業收入、費用、利潤、損失、淨利潤或虧損和其他全面收益或虧損,其中包括歸屬於母公司所有者和非控制權益的金額。
未經審計的中期財務報告
隨附的未經審計的中期簡明綜合財務報表是根據美國公認會計原則(「GAAP」)和證券交易委員會(「SEC」)關於中期財務報告的適用規定和法規編制的。因此,它們不包括所有完整綜合財務報表所需的所有信息和相關附註。在管理層的意見中,所有調整,包括經常性應計項目,被認爲是爲了公正展示財務報表而包括在內。截至2023年12月31日的附屬的綜合資產負債表是從經審計的財務報表中衍生出來的,但沒有包括GAAP規定的所有披露。因此,應當閱讀這些未經審計的中期簡明綜合財務報表,結合公司於2023年12月31日年報中與之相關的經審計的綜合財務報表和附註,該年報已於2024年2月28日提交給SEC,以了解完整情況。
12


使用估計
根據GAAP要求,編制符合會計準則的合併基本報表需要管理層進行估計和假設,這些估計和假設會影響基本報表中資產和負債的報告金額,以及合併基本報表日期時的有關資產和負債的披露,以及在報告期內的營業收入和費用的報告金額。實際結果可能與這些估計不同。伴隨的簡明合併基本報表中的重大估計包括營收確認指引的應用;無形資產和商譽減值;有關考慮的計價;以及遞延稅資產的減值準備。
演示內容變更
如前述,在公司截至2023年12月31日的年度報告10-k中披露的信息,從2024年1月開始,公司的FounderShield合作伙伴從承保、容量與科技解決方案業務群轉移到保險諮詢解決方案業務群。請注意,註釋14中的去年部門報告信息已經根據當前的組織結構進行重新調整。
此外,爲符合當前年度報表的要求,特定的往年金額已進行了重新分類。這些重新分類對公司此前報告的綜合財務狀況或經營業績沒有影響。
最近發佈的會計準則
2023年12月,財務會計準則委員會(「FASB」)發佈了《會計準則更新》(「ASU」)2023-09號,所得稅(主題740)-改善所得稅披露(「ASU 2023-09」),以提高所得稅披露的透明度和有用性。ASU 2023-09要求披露具體類別,並在稅率協調錶中使用百分比和報告貨幣金額對信息進行細分。ASU 2023-09還要求披露與已支付的所得稅有關的細分信息,繼續經營前的所得稅費用或利潤,以及繼續經營的所得稅費用或利益。該指南適用於2024年12月15日後開始的財政年度。公司預計採用這一標準將擴大其所得稅披露,但不會對合並財務報表產生其他影響。
近期採納的會計準則
2023年11月,FASb發佈了ASU No. 2023-07,分部報告(主題280)—改進可報告分部披露(「ASU 2023-07」),以加強對可報告分部的披露要求。ASU 2023-07要求定期披露向首席營運決策者(「CODM」)提供的重要分部費用,以及包括在分部利潤或損失中的其他分部項目的總金額及其構成的描述。此外,ASU 2023-07還要求描述CODM如何利用報告的分部運營結果度量來評估分部績效。ASU 2023-07還要求加強期中披露要求,有效使年度披露成爲期間報告的要求。ASU 2023-07的年度要求於2024年1月1日對公司生效,並於此時採納。公司將在其截至2024年12月31日的年度報告10-K中按要求包含新的披露內容。對於從2025年1月1日開始的財年,將需要新的期中披露,並將在那時納入公司的10-Q季度報告中。
2. 業務剝離
自2020年1月推出以來,公司的特色批發經紀業務(「批發業務」),在承保、容量和科技解決方案運營集團內運營,未能像零售和MGA業務那樣獲得同等程度的資本配置、關注和優先考慮。在評估批發業務的各種發展方向後,管理層在2023年年底附近得出結論,計劃出售批發業務爲公司和批發業務創造了最大的機會。
截至2023年12月31日,批發業務符合作爲待售分類的條件。資產和負債按其賬面價值列示爲待售,該價值被確定爲低於淨資產的公允價值減去出售成本,因此,與重新分類相關的損失未予記載。剝離未滿足停止經營的報告條件,公司繼續在截至2024年2月29日的綜合損益簡表中報告其批發業務的營運結果。
13

2024年3月1日,公司完成了其批發業務的出售,銷售額約爲$58.9 百萬美元,經過一些慣例的購買價格調整。公司取消了$61.8 收購協議包括若干績效指標,若實現這些指標,則可能觸發向原始出售股東的額外支付。有條件安排包括最多$target milestones million的支付,該支付基於與戰略目標掛鉤的某些定義里程碑的及時完成,以及最多$percentage of orders received million的支付,該支付基於所需收到收益期內收到訂單的百分比。收益期爲收購之日後,或者在滿足某些條件前。9.5 百萬元的資產淨值和$39.9 百萬元的負債。公司確認了出售產生的稅前收益$35.1 百萬元(經過收盤後調整),這被包括在2024年9月30日止九個月的綜合損益簡明合併報表中作爲剝離業務的損益組成部分。
3. 變量利益實體
根據主題810,報告實體在具有變量權益或組合的情況下,需要合併變量實體(「VIE」),以使實體對VIE具有控制財務權益。公司持續評估是否對其各個VIE擁有控制財務權益,以確定是否是VIE的主要受益方,因此應合併每個VIE。如果報告實體具有對VIE指導最重要的影響的活動的權力,以及承擔VIE的損失或有權從VIE獲益的責任可能對VIE具有重大影響,則被認爲對VIE具有控制財務權益。
公司確定其爲其可變利益實體(VIEs)的主要受益人,其中包括Laureate保險合作伙伴有限責任公司,BKS Smith有限責任公司,BKS MS有限責任公司和BKS Partners Galati Marine Solutions有限責任公司。公司已將其VIEs合併到附帶的簡明綜合基本報表中。
公司合併的VIEs的總收入和支出分別包含在綜合損益簡明綜合報表中,分別爲$0.6萬美元和0.2 百萬美元,截至2024年9月30日的三個月分別爲$0.4萬美元和0.3 百萬美元,截至2023年9月30日的三個月分別爲$1.8萬美元和0.8 百萬美元,截至2024年9月30日的九個月分別爲$1.4萬美元和0.8 分別爲截至2023年9月30日的九個月的1100萬美元和1300萬美元。
公司合併VIE的總資產和負債分別包括在簡明合併資產負債表上,分別爲$1.5萬美元和0.3 百萬,分別爲2024年9月30日和$0.8萬美元和0.2 百萬,分別爲2023年12月31日。合併VIE的資產僅可用於清償合併VIE的債務,而合併VIE的債務債權人無權追索公司。
4. 營業收入
以下表格按主要來源提供了分項收入:
三個月期間
截至9月30日結束
九個月期間
截至9月30日結束
(以千爲單位)2024202320242023
佣金收入(1)
$270,271 $237,103 $873,051 $737,815 
分紅營業收入(2)
26,785 25,959 69,757 75,877 
諮詢和服務費營業收入(3)
19,257 21,735 58,011 57,947 
保單費和分期付款手續費收入(4)
16,002 17,071 43,252 49,907 
其他收入(5)
2,895 2,364 6,338 7,760 
投資收益(6)
3,728 2,038 8,736 4,601 
總收入$338,938 $306,270 $1,059,145 $933,907 
__________
(1)    通過與保險公司合作,在直接賬單和代理賬單安排下,爲客戶提供保險放置服務而實現佣金收入,涵蓋私人風險管理、商業風險管理、财富管理、員工福利和醫療保險等類型。
(2)    分紅收入代表某些保險公司合作伙伴提供的作爲銷售激勵的獎金類型收入。
(3)    服務費用收入是通過向客戶提供保險放置服務收取協商費用獲得的,諮詢收入則是通過提供專業保險諮詢和其他諮詢服務獲得的。
14

(4)    保單費用收入代表以MGA身份行事,並代表保險公司合作伙伴履行某些行政職能所賺取的收入,包括提供保單文件、處理付款和其他行政職能。分期付款費用收入代表公司代表保險公司合作伙伴提供與分期支付有關的保單保險費的付款處理服務所賺取的收入。
(5)其他收入包括其他輔助收入、保費融資收入,以及基於達成協議的成本補償而得的營銷收入,用於履行特定目標的醫療保險營銷活動。
(6)投資收入代表在可投資的資金中獲得的國庫貨幣市場基金利息收入。
應用ASC 606主題, 與客戶簽訂合同的營業收入 (主題606)需要運用管理層判斷。以下是與主題606相關的最重要判斷領域:
公司認爲,在絕大多數合約關係中,保單持有人代表其客戶,但在其Mainstreet保險方案運營集團的醫療保險合同中,保險公司合作伙伴被視爲其客戶。
醫療保險解決方案運營團隊的醫療保險合同是多年的安排,在這種安排中,公司有權獲得續約佣金。然而,公司對續約佣金應用了限制條件,限制在存在重大風險逆轉風險時承認的收入,這取決於:(i)歷史續約模式;和(ii)公司無法控制的外部因素的影響,包括被保險人對計劃和保險公司合作伙伴關係的自主權、政治影響以及限制公司有權獲得續約佣金的合同規定,該規定將公司獲得續約佣金的權利限制在繼續遵守相關保險公司合作伙伴的合規性和監管審批以及符合醫療保險與醫療補助服務中心的規定。
公司在保險投放生效日期單獨確認委託佣金營業收入,並認爲與客戶的任何持續互動在合同義務的背景下是微不足道的。
變量考慮包括直接賬單佣金的估計、保單取消的準備金和利潤分成收入的預提。
爲獲取合同而發生的成本被推遲並分期確認 月內。2023年和2022年的三個和九個月期權授予均以授予日公司普通股的公允價值相等的行權價格授予,並且是非法定股票期權。,這代表管理層對新業務的平均受益期的估計。
由於信息收集階段和綁定保險覆蓋之間的時間相對較短,公司已確定履行合同的成本不重要。因此,按發生的方式計入履行合同的成本。
5. 合同資產和負債
合同資產是指公司確認的尚未開具賬單的收入和代保險公司合作伙伴應收保費。合同負債涉及在履行合同之前收到的支付,即在將產品或服務轉交給客戶之前。合同資產包括應收保費、佣金和費用淨額,而合同負債包括在精簡合併資產負債表中的預提費用和其他流動負債。 與客戶簽訂的合同產生的合同資產和負債餘額如下:
(以千爲單位)2024年9月30日2023年12月31日
合同資產$349,286 $342,692 
合同負債40,030 30,281 
截至2024年9月30日止的九個月內,公司確認了10月1日至12月31日的營業收入$29.8 百萬,與2023年12月31日的合同負債餘額有關。
15

6. 延遲佣金支出
公司根據ASC 340主題,在新業務上支付額外的補償金額,以製作人佣金的形式。 其他資產和推遲費用 這些額外成本被推遲並攤銷至 月內。2023年和2022年的三個和九個月期權授予均以授予日公司普通股的公允價值相等的行權價格授予,並且是非法定股票期權。,這代表管理對新業務平均受益期限的估計。推遲的佣金支出代表資本化的製作人佣金,尚未支出,幷包含在簡明合併資產負債表的其他資產中。 下表提供了推遲佣金支出的詳細情況:
三個月期間
截至9月30日結束
九個月期間
截至9月30日結束
(以千爲單位)2024202320242023
期初餘額$29,434 $24,840 $26,205 $21,669 
成本資本化5,930 2,666 13,547 9,170 
攤銷(2,638)(1,847)(7,026)(5,180)
期末餘額$32,726 $25,659 $32,726 $25,659 
7. 應計費用及其他流動負債
應計費用和其他流動負債包括以下內容:
(以千爲單位)2024年9月30日2023年12月31日
應計的薪酬和福利$59,504 $53,728 
合同負債40,030 30,281 
經營租賃負債流動部分17,659 16,704 
應計利息16,182 2,009 
應計費用9,987 23,274 
開多次數8,400 10,243 
同事的尾款激勵(1)
7,581 8,020 
其他4,959 8,695 
應計費用及其他流動負債$164,302 $152,954 
__________
(1)    代表未支付的有條件收購責任的部分,經合作伙伴選擇,轉爲應付給同事的業績激勵獎金。有關有條件收購責任的變動情況,請參閱附註12中的有條件收購責任展示。
8. 長期債務
截至2023年12月31日,經修訂的摩根大通信貸協議規定優先擔保信貸額度總額爲美元1.62十億美元,其中包括 (i) 本金爲美元的定期貸款額度1.02將於2027年10月到期的10億美元(「定期貸款B」)和(ii)循環信貸額度,承諾本金總額爲美元600百萬美元將於2027年4月到期(「循環基金」)。定期貸款 b 按期計息 軟弱 再加上兩者之間的信用利差調整 11 bps 和 43 bps,基於該術語 軟弱 費率,加上適用的利潤率 350 bps,以 SOFR 下限爲一詞爲準 50 bps。循環融資機制下的借款應計利息爲 軟弱210 bps 到 軟弱310 點子基於總淨槓桿比率。
2024年5月24日,寶德威控股用發行的部分收益爲定期貸款b和循環融資機制下的未償金額進行了再融資600本金總額爲百萬美元 7.1252031年5月15日到期的優先有擔保票據(「優先擔保票據」)和新美元以下借款的百分比840百萬美元優先擔保第一留置權定期貸款,將於2013年5月24日到期(「2024年定期貸款」)。在再融資方面,寶德溫控股公司還建立了新的優先擔保第一留置權循環基金,承諾本金總額爲 $600百萬美元將於2029年5月24日到期(「2024年循環貸款」,連同2024年的定期貸款,「2024年信貸額度」)。
16

關於高級擔保票據和2024年授信額度,公司共計承擔了$32.0 百萬美元的債務發行成本,其中$18.0 百萬美元被資本化爲遞延融資成本,將在相關債務的期限內分期攤銷。大部分遞延融資成本與高級擔保票據和2024年貸款相關,並記錄爲簡化合並資產負債表上長期債務的抵消,而與2024年循環信貸工具相關的成本則計入其他資產。剩餘的$14.0 百萬美元的成本,由涉及貸款修訂部分的第三方融資成本構成,這部分貸款在2024年9月30日結束的九個月內被直接支出。公司還因2024年9月30日結束的九個月,對部分清償的Term Loan b錄得了額外損失$1.0 百萬美元。所有先前未攤銷的遞延融資成本繼續根據2024年貸款和2024年循環信貸工具的期限適當進行攤銷。合併債務清償和修訂損失總計$15.1 百萬美元單獨報告在2024年9月30日結束的九個月的簡化合並綜合損益表中。
優先擔保票據。
高級擔保票據由Baldwin Holdings及Baldwin Holdings的全資企業子公司(「共同發行人」和與Baldwin Holdings共同爲「發行人」)根據日期爲2024年5月24日的”證券託管書“簽發,簽署方包括髮行人、其中列名的擔保方以及作爲託管人和票據抵押品代理的美國銀行信託公司國家協會。高級擔保票據的利息將在每年5月15日和11月15日拖欠後半年支付一次,從2024年11月15日開始。這些高級擔保票據由擔保方共同、分別和無條件擔保,擔保或將擔保2024年信貸框架下的債務(「擔保」); 高級擔保票據及擔保在維護人和擔保人的所有現有和未來高級債務方面與2024年信貸框架下的債務一視同仁,並由維護2024年信貸框架下債務抵押品中第一優先權依據抵押。
優先擔保票據可以在2027年5月15日當天或之後隨時按契約中規定的贖回價格以及應計和未付利息進行全部或部分贖回。在2027年5月15日之前,發行人還可以以等於的價格贖回部分或全部優先擔保票據 100其本金的百分比,加上應計和未付利息,加上契約中描述的適用的 「整體」 保費。此外,發行人可以在2027年5月15日之前贖回 (i),直至 40優先擔保票據(包括其他票據,如果有)當時未償還本金的百分比,其金額不超過某些股票發行的淨現金收益,贖回價格等於 107.125本金總額的百分比,以及 (ii) 2027 年 5 月 15 日之前的任何時間,直至 10優先擔保票據發行之日後的任何十二個月期間(前提是從優先擔保票據發行之日起的期限應於2025年5月15日結束),當時未償還的優先擔保票據(包括其他票據,如果有)本金的百分比,贖回價格等於 103在每種情況下,其本金總額的百分比,加上截至贖回日的應計和未付利息(如果有)。此外,如果發生某些類型的 「控制權變更」,發行人必須提議按契約中規定的價格購買優先擔保票據,外加截至購買之日但不包括應計和未付利息(如果有)。
董事會統治高級擔保票據的契約包含條款,限制發行人及其受限子公司的能力,包括但不限於:
增加額外債務或發行特定優先股;
承擔留置權或將資產用作安防-半導體在其他交易中;
進行特定分配、投資和其他受限制的支付;
與關聯方進行某些交易;以及
合併、整合、出售、轉讓、出租或以其他方式處置其所有或幾乎所有資產。
發行人在2024年9月30日遵守了所有此類契約。
該契約還規定了慣例的違約事件。
2024年信貸設施
2024年期貸款發行於 99.75與面值的%並按期利率計息 SOFR, 再加上適用的利差 325 個點子,且在第一抵押淨槓桿率爲4.00倍或更低時,利率下調至 300 百萬美元,截至2024年9月30日,2024年期貸款的未償還借款爲837.9 百萬元,適用利率爲 8.10%.
17

2024年貸款條款下的未償還借款需要進行預付:(a) 最多 50現金流的 25%和0如果達到指定總頭等留置淨槓桿比率的 100某些資產處置的淨現金收益的 100違反2024年信貸協議而產生的債務的
2024年貸款期需要每季度償還本金$2.1 百萬,餘額應在到期日全額償還。每季度攤銷支付可通過任何強制或自願的預付款項來減少,包括超額現金流支付。
2024年循環信貸設施的利率是定期 SOFR,再加上bps的信貸溢價調整 10 ,再加上bps的適用按金 200 ,再根據總的第一優先權淨槓桿率增加至bps 300 個基礎點。2024年循環信貸設施在2024年9月30日尚有 未償還借款;但是,2024年循環信貸設施需要支付承諾費用 0.40在2024年9月30日未使用的產能百分比,可能會減少至 0.35%, 0.30大約0.25如果總淨槓桿率未來降至某些特定水平,則公司將支付與2024年循環設施下期限SOFR貸款的按金相等的信用證費,乘以任何信用證下可提取的每日金額,前期費用和根據2024年信貸協議發行的任何信用證的任何慣例文件和處理費。
2024年信貸安排下的所有債務均由鮑德溫控股公司的某些直接和間接附屬公司(即「擔保方」)以聯合、 Severally和無條件擔保的方式提供擔保,這些公司也擔保了Senior Secured Notes,但受到某些法律和稅務限制以及其他約定的例外的限制,並且受到鮑德溫控股和擔保方的幾乎所有資產的擔保,但受到某些約定的限制。
2024年信貸協議是2024年信貸額度的最終協議,規定寶德威控股公司有權隨時申請增量貸款,本金總額不超過 (a) (1) 美元中較大者之和285.0百萬和 (2) 100最近完成的有內部財務報表的四個財政季度的合併息稅折舊攤銷前利潤(定義見2024年信貸協議)的百分比,以及(b)定期貸款額度的所有自願預付款和/或贖回以及某些其他債務,與2024年信貸額度下的債務以及2024年循環融資機制的所有自願承諾削減(以發生的收益爲擔保的範圍除外)長期債務)加上(c)這樣的金額在根據本條款 (c) 實施任何此類增量融資機制之後(假設該增量循環貸款的全部金額已提取,則應視爲包括任何增量循環貸款的全部金額),在使任何收購、處置、債務產生、債務退還和其他與之相關的交易生效之後,寶德溫控股在預計基礎上將遵守總額度第一留置權淨槓桿率爲 5.50x 或以下。根據2024年信貸協議,貸款人沒有任何義務提供任何此類增量貸款,任何此類增量融資都將受某些慣例條件的約束。
2024年信貸協議包含特定的財務、肯定和否定契約條款,這些條款對於這種類型的高級信貸安排來說是慣例的。 2024年信貸協議中的否定契約包括對鮑德溫控股及其主要子公司的能力施加限制(受約定例外的約束),使其不得:
承擔額外的債務(包括擔保);
負擔留置權;
進行投資、貸款和預付款;
實施合併、整合和資產的銷售(包括出售和回租交易);
禁止支付或簽訂限制性協議(包括帶有負債限制條款的協議);
與關聯方進行不公允條件的交易;
更改由Baldwin Holdings及其子公司進行的業務;
預付款,或對指定債務進行贖回和回購。
以2024年信用協議下的貸款款項用於某些被禁止的方式;
對Baldwin Holdings及其主要子公司的組織文件進行必要修訂;和
更改鮑德溫控股的財政年度。
18

2024年的信用協議包含一個財務維持契約,要求鮑德溫控股公司在資產負債表的淨槓桿率總和保持在或低於 7.00 對應披露基礎上的1.00。2024年的信用協議還包含特定的違約事件和相應的違約期限。截至2024年9月30日,鮑德溫控股公司遵守了所有這些契約。
利率上限
該公司使用利率上限通過限制利率變動對現金流的影響來減輕其債務的利率風險敞口。利率上限將適用基準利率的可變性限制爲上限金額。利率上限作爲其他資產的一部分包含在簡明的合併資產負債表中,按低於美元的總公允價值進行記錄0.1百萬和美元2.6截至2024年9月30日和2023年12月31日,分別爲百萬人。公司確認利率上限虧損爲美元0.1百萬和美元0.2截至2024年9月30日的三個月和九個月中分別爲百萬美元,利率上限虧損爲美元0.8百萬和美元0.5在截至2023年9月30日的三個月和九個月中,分別爲百萬美元。利率上限的收益或虧損作爲其他收入(支出)的組成部分包括在簡明的合併綜合虧損報表中。
9. 關聯交易
關聯方餘額
截至2024年4月30日和2024年1月31日,公司的現金及現金等價物合計爲$百萬。1.52023年12月31日應收來自關聯方的款項約爲**萬美元,其中包括根據合夥協議所規定的合作伙伴應付的發帖現金需求金額。2023年12月31日的應收款項也包括向Emerald Bay Risk Solutions, LLC(以下簡稱emerald Bay)貸款的**萬美元,該實體旨在爲MGA業務提供利益,並由Baldwin Holdings、Lowry Baldwin、公司主席及公司高管團隊成員承擔資產承諾。來自關聯方的款項包括在預付費用和其他流動資產中。0.8**萬美元的貸款是爲Emerald Bay Risk Solutions, LLC(以下簡稱emerald Bay)提供的,該實體是爲了MGA業務的利益而成立的,Baldwin Holdings、Lowry Baldwin、公司主席以及公司的高管團隊成員都有資產承諾。來自關聯方的款項包括在壓付費用和其他流動資產中。
鮑德溫控股公司在2024年9月30日結束的九個月內,記錄了對翡翠灣的投資金額。2.4投資金額已包括在簡明綜合資產負債表的其他資產中。
2024年9月30日和2023年12月31日分別達到$百萬的關聯方應付票據,與公司的某些合作伙伴的盈利分享權益結算有關。5.61百萬美元和1.52024年9月30日和2023年12月31日分別達到$百萬的關聯方應付票據,與公司的某些合作伙伴的盈利分享權益結算有關。
佣金收入
公司作爲村莊控股公司的經紀人(「村莊」),一個重要的股東以及某些關聯實體的經紀人。從與村莊及其關聯實體進行的交易中記錄的佣金收入爲$0.1萬美元和0.4 萬美元,以及2024年和2023年截至9月30日的九個月分別爲$2.41百萬美元和2.0百萬美元分別於2024年和2023年截至9月30日的九個月中確認的收入。
該公司爲某些實體充當經紀人,這些實體中有鮑德溫董事會成員存在重大利益。與這些實體交易所產生的佣金收入爲$0.1此外,在截至2021年3月31日和2020年12月31日的三個月中,公司分別錄得向Vouched支付了$百萬美元和少於$百萬美元的款項,Vouched是一家提供身份驗證服務的關聯方公司。這些費用被認爲是銷售、一般和行政費用。截至2021年3月31日和2020年12月31日,欠Vouched的賬款分別爲$百萬美元和少於$百萬美元。0.1 萬美元,以及2024年和2023年截至9月30日的九個月分別爲$0.1萬美元和0.2 截至2024年9月30日和2023年,分別爲百萬美元。
佣金支出
公司主席洛瑞·鮑德溫的兩個兄弟從公司獲得了約$的製片佣金。0.1萬美元和0.2 ,分別在截至2024年和2023年9月30日的三個月內認定爲$百萬和$百萬0.4萬美元和0.5 百萬。
租金費用
公司與The Villages的全資子公司簽訂了各種辦公空間租賃協議。與The Villages及其全資子公司相關的總租金費用約爲$0.12024年和2023年9月30日結束的三個月中,每月均爲$0.41百萬美元和0.32024年和2023年9月30日結束的九個月中,分別爲$,公司的簡明合併資產和運營租賃負債包括與這些租賃協議相關的財務狀況表上的每一項爲$1.11百萬美元和1.2 百萬,2023年12月31日分別爲$1.4 2013年12月31日,公司的資產租賃權利和營運租賃負債總額分別爲$
19

公司與其他關聯方簽訂了各種辦公場所租賃協議。截至2024年和2023年9月30日,公司與其他關聯方發生的全部租金支出爲$0.9萬美元和1.0 截至2024年9月30日和2023年,分別爲百萬美元。2.8萬美元和2.9 百萬。公司簡明合併資產負債表中包括與這些租賃協議相關的全部租賃資產和經營租賃負債爲$10.61百萬美元和11.1 百萬,2023年12月31日分別爲$12.91百萬美元和13.4分別爲2023年12月31日的300萬和200萬。
公司擁有一項活躍的股權激勵計劃,即Alight, Inc. 2021 Omnibus Incentive Plan(「激勵計劃」),根據該計劃,公司已獲得授權向關鍵員工和非僱員董事授予股權激勵,包括限制性股票單位(「RSUs」)和績效股票單位(「PRSUs」)。根據該計劃,在2024年6月30日結束的6個月期間發放的授予,約爲
公司設有綜合激勵計劃(「綜合計劃」)和合夥誘因獎勵計劃(「誘因計劃」,與綜合計劃合稱爲「計劃」),旨在激勵和獎勵同事和特定其他個人表現出色,對公司的成功做出重要貢獻,從而進一步促進鮑德溫股東的最大利益。截至2024年9月30日,根據綜合計劃和誘因計劃授權發行的A類普通股的總數量爲 10,793,0353,000,000,分別爲2024年9月30日。
2024年9月30日結束的九個月期間,公司向非僱員董事、官員、同事和顧問發放了受限制的股票獎勵(RSAs)、基於績效的限制性股票單位獎勵(PSUs)和完全授予計劃下的股份。2024年9月30日結束的九個月期間,發放給董事、官員和同事的完全授予股份在發行時即可獲得,發放給官員的PSUs將在績效期結束後的季度獲得,而發放給同事、顧問和官員的RSAs通常在發放後要麼在…之後即時獲得。 三年,而發放給同事、顧問和官員的RSAs通常要麼在…之後一次性獲得。 公司使用資產和負債的會計方法來計算所得稅。根據這種方法,根據資產和負債的金融報表及稅基之間的暫時區別,使用實施稅率來決定遞延稅資產和遞延稅負債,該稅率適用於預期差異將反轉的年份。稅法的任何修改對遞延稅資產和負債的影響將於生效日期在財務報告期內確認在彙總的綜合收益報表上。 或在…期間均勻獲得。 月內。2023年和2022年的三個和九個月期權授予均以授予日公司普通股的公允價值相等的行權價格授予,並且是非法定股票期權。.
以下表格總結了公司根據計劃授予的獎勵的活動情況:
股份每股加權平均授予日公允價值
2023年12月31日未實現授予獎項
3,521,590 $29.22 
已行權
1,847,756 30.39 
已獲授和已結算
(1,350,885)27.20 
被取消
(298,182)29.75 
2024年9月30日未實現授予獎項
3,720,279 30.49 
獲得並根據計劃結算的股票的總公允價值爲$36.7萬美元和29.6 截至2024年9月30日和2023年,分別爲百萬美元。
股份報酬按照各自獎勵的實現期間平均確認,包括與計劃下發相關的支出。股份報酬還包括以A類普通股完全實現的年度獎金部分。公司淨額確認計劃的股份報酬支出,考慮實際棄權。公司分別於截至2024年9月30日和2023年結算了股份報酬支出$17.9萬美元和14.6 截至2024年9月30日和2023年,分別爲百萬美元。46.8萬美元和46.6 百萬,包括在綜合損益表的佣金、僱員薪酬和福利支出中。
20

11. 每股盈利(虧損)
每股基本盈利(虧損)是通過將歸屬於鮑德溫的淨利潤(虧損)除以該期間內流通的A類普通股的加權平均股數來計算的。每股攤薄盈利(虧損)是考慮到所有可能具有稀釋效應的普通股而計算的。
以下表格列出了基本每股損失和攤薄每股損失的計算方法:
三個月期間
截至9月30日
九個月期間
截至9月30日
(以千爲單位,除每股數據外)2024202320242023
基本和攤薄每股虧損:
歸屬於鮑德溫的淨虧損
$(8,377)$(17,629)$(4,356)$(55,658)
用於計算每股基本和稀釋虧損的股份數量:
普通A類股權基本和攤薄加權平均股份64,01260,54963,00159,791
每股基本和攤薄虧損
$(0.13)$(0.29)$(0.07)$(0.93)
潛在稀釋證券包括未獲授予的股票獎勵,包括 RSAs 和 PSUs,以及份額不屬於公司 B 類普通股的股票,這些股票可以按 1:1 比例(連同相應數量的 LLC 單位)換取公司 A 類普通股。 以下潛在稀釋證券未計入公司被稀釋後的加權平均流通股數計算,因爲如果計入這些證券將無益稀釋。
三個月期間
截至9月30日
九個月期間
截至9月30日
2024202320242023
未投資的受限股份獎勵和績效單位4,014,508 3,880,052 3,569,891 3,880,052 
B類普通股份的股份50,490,324 52,486,094 51,234,449 52,486,094 
Class b普通股不參與歸因於Baldwin的收益或損失,因此不屬於參與式證券。因此,在兩類方法下未包括Class b普通股的基本和稀釋每股虧損的單獨表述。
12. 公允價值衡量
ASC主題820 公允價值計量 《主題820》建立了一個衡量公允價值的框架。該框架提供了一個公允價值層次結構,優先考慮用於衡量公允價值的估值技術中的輸入。該層次結構最優先考慮在活躍市場上的未經調整的報價價格來衡量相同資產或負債(一級衡量),最低優先考慮無法觀察的輸入(三級衡量)。在《主題820》下,公允價值層次結構的三個級別如下:
一級:估值方法的輸入是公司可以獲取到的活躍市場上相同資產或負債的未經調整的報價。
二級:估值方法的輸入包括類似工具在活躍市場中的報價、在非活躍市場中相同或類似工具的報價以及基於模型的估值技術,其中所有重要假設在市場上都是可觀察的。
三級:估值方法的輸入不可觀測且對公允價值測量有重要影響。
資產和負債的公允價值測量級別取決於對公允價值測量具有重要影響的任何輸入的最低級別。使用的估值技術需要最大程度地利用可觀察的輸入,並儘量減少不可觀察的輸入的使用。
21

以公允價值計量的資產和負債的重複計量
以下表格總結了公司資產和負債,在公允價值層次結構的每個級別內定期衡量的情況:
公允價值層次結構
第 1 級第 2 級第 3 級
(以千計)2024 年 9 月 30 日2023 年 12 月 31 日2024 年 9 月 30 日2023 年 12 月 31 日2024 年 9 月 30 日2023 年 12 月 31 日
資產:
貨幣市場基金$21,962 $4,317 $— $— $— $— 
利率上限— — 18 2,562 — — 
按公允價值計量的總資產$21,962 $4,317 $18 $2,562 $— $— 
負債:
或有收益負債$— $— $— $— $203,790 $276,467 
以公允價值計量的負債總額$— $— $— $— $203,790 $276,467 
貨幣市場基金
公司在貨幣型基金中進行投資,這些投資包括在簡明綜合資產負債表中的現金及現金等價物中。這些投資的公允價值輸入被視爲公允價值層次中的一級測量,因爲貨幣型基金公允價值是通過每日發佈的浮動價值來確認和觀察的。
利率上限
利率期貨的公允價值是根據市場標準的方法確定的,即將未來預期現金收入貼現,如果變量利率上升超過上限價格,將發生。在對上限的預期收入進行計算時使用的變量利率基於從可觀察市場利率曲線和波動性推導出的未來利率預期。
附帶業績補償責任
在公平價值分層結構中,用於定期基礎上衡量的負債的方法基於有限的不可觀察輸入。這些方法可能產生一個公平價值計算,該計算可能不代表淨實現價值或未來公平價值。此外,儘管公司認爲其估值方法是適當的並與其他市場參與者一致,但使用方法或假設來判斷某些金融工具的公平價值可能會導致在報告日期有不同的公平價值計量。
對於收購實體的銷售預測基礎上,待實現的盈利分成責任的公平價值是根據每個報告期重新評估。根據公司對待實現的盈利分成責任的公平價值持續評估,公司記錄了此類責任估計公平價值的淨下降$。1.0截至2024年9月30日的三個月,公司待實現的盈利分成責任的估計公平價值淨增加$。17.3截至2024年9月30日的九個月,公司待實現的盈利分成責任的估計公平價值淨增加$。公司已評估到2024年9月30日,待實現的盈利分成責任的最大估計暴露爲$。329.2 2024年9月30日,公司評估了待實現的盈利分成責任的最大估計暴露爲$。
公司每個報告期利用公平價值層次結構中歸類爲Level 3的顯著不可觀察輸入來衡量待定盈利分成責任。公司採用概率加權價值分析作爲一種估值技術,將未來預估現金流量轉換爲單一現值金額。在公平價值測量中使用的顯著不可觀察輸入包括盈利分成期間的銷售預測,以及分配給每種情景的概率結果百分比。對這些輸入中的任何一個出現顯著增加或減少都將導致較高或較低的責任,較高的責任被待定盈利分成責任的合同最大限額所限。最終,責任將等同於結算金額,公允價值估計與結算金額之間的差額將記錄在業務組合收入中,或記錄爲資產收購中資產賬面價值的變動。
22

依據蒙特卡洛模擬進行的清償計算負債的公允價值,衡量了按照各自購買協議中規定的條款向合作伙伴支付的未來預期支付的現值,這屬於3級公允價值測量。在確定公允價值時,公司利用管理層爲合作伙伴制定的財務預測以及爲營收增長、跟蹤的租賃單元數量或所提供的房屋保險價值推導出的市場參與者假設來估計合作伙伴的未來表現。營收增長率一般範圍從 8可以降低至0.75%每年25%到2024年9月30日和從 10可以降低至0.75%每年35%到2023年12月31日。公司通過清償公式和每份購買協議規定的績效目標以及這些財務預測來估計未來的支付。這些支付一般按照考慮了反映合作伙伴實現目標能力的市場利率的風險調整利率貼現到現值。這些折現率一般在2023年12月31日範圍內從 7.50可以降低至0.75%每年13.75%。然而,由於2024年9月30日任何剩餘重要清償公債務的短期性質,未對剩餘餘額應用折現率。財務預測、營收增長的市場參與者假設或風險調整折現率的變化將導致清償計算公允價值的變化。
下表列出了公司待收款項責任公允價值的變化摘要,這些責任以重複利用第三級假設進行估值。
三個月期間
截至9月30日
九個月期間
截至9月30日
(以千爲單位)2024202320242023
期初餘額$210,243 $294,312 $276,467 $266,936 
應計可變對價公允價值變動(1)
(952)13,914 17,276 55,065 
有條件的考慮發行的公允價值 723  723 
結算相關考慮(2)
(5,501)(35,672)(89,953)(49,447)
期末餘額$203,790 $273,277 $203,790 $273,277 
__________
(1)    公司通過發行同事盈利激勵重新分類了$4.31百萬美元和10.7在2024年9月30日結束的三個和九個月內,公司將其作爲同事盈利激勵的核算賺取權責任重新分類了$百萬。這導致了有條件出售考慮變動的減少,並增加了在綜合損益簡明合併報表中的佣金、員工薪酬和福利費用。有關同事盈利激勵餘額的更多信息,請參閱附註7。
(2)公司通過發行關聯方應付票據結清了$5.6在截至2024年9月30日的九個月內,公司通過發行關聯方應付票據結清了數百萬美元的計提盈餘支付責任。2024年9月30日止九個月的簡明合併現金流量表中包括了$1.5數百萬美元有關類似非現金結算的計提盈餘支付在早前一期的款項在2024年9月30日止九個月的簡明合併現金流量表中支付。
其他金融工具的公允價值
長期負債和循環信貸的公允價值是基於使用折現現金流分析和類似借款安排的當前借款利率的估計。 長期負債和循環信貸的賬面價值和預計公允價值如下:
公允價值層次結構2024年9月30日2023年12月31日
(以千爲單位)公允價值預估
公正價值
開多餘額預估
公正價值
長期債務(1)
二級$1,437,900 $1,466,400 $998,737 $997,489 
循環授信額度二級  341,000 335,963 
__________
(1)    長期債務的賬面價值反映了未償債務,其呈現爲減去未攤銷債務發行成本款項,分別爲截至2024年9月30日和2023年12月31日的簡明合併資產負債表。30.5萬美元和20.3 截至2024年9月30日和2023年12月31日的簡明合併資產負債表上反映了尚未償還借款的長期債務金額,分別爲
13. 承諾和事項
承諾
截至2024年9月30日,創立投資有限公司對南佛羅里達大學(「USF」)有着一項剩餘承諾,即向其捐贈$4.2 百萬美元,捐贈將支持南佛羅里達大學穆瑪商學院風險管理與保險學院的發展。目前預計,該公司董事長洛瑞·鮑德溫將資助創立投資的一半捐款。
23

法律訴訟
公司涉及各種索賠和法律訴訟,在業務常規過程中產生。根據GAAP的規定,當損失被認爲是可能發生的並且是可以合理估計的時候才會記錄一項責任。當重要損失的不確定性是可能的但不是概率上的時,公司會披露索賠的性質,以及可能如果能的話將損失或損失範圍進行估計。在管理層的看法中,這些事項的最終解決將不會對公司的綜合財務狀況、經營業績或流動性產生重大不利影響。
在2023年,公司的聲稱A類股東Ruby Wagner代表自己和其他類似處境的股東在特拉華州莊士理法院提起了一起集體訴訟(「訴訟」),要求莊士理法院裁定公司與IPO前LLC成員之間2019年股東協議的某些條款違法並不可執行。2024年5月28日,莊士理法院作出意見書(「莊士理法院意見書」),認定2019年股東協議中授予批准權的相關條款涉及修訂公司章程以及對公司高級管理層做出重大決定的部分在特拉華州法律下是表面無效、無效且不可執行的。一項現行的實施命令於2024年6月20日簽發。莊士理法院意見書還指出2019年股東協議的可分割條款允許IPO前LLC成員要求對被認定無效的批准權提供「合適和公平的替代」。訴訟尚未作出最終裁定,上訴期限尚未屆滿。目前管理層無法估計此事項最終處理可能造成的潛在損失或損失區間。
14. 部門信息
從2024年1月1日起,公司的FounderShield合作伙伴從覈保、容量和技術解決方案運營集團轉至保險諮詢解決方案運營集團。本說明中的往年分部報告信息已經重組以符合當前的組織結構。
鮑德溫的業務分爲 運營集團:保險諮詢解決方案、覈保、容量和 科技解決方案和主街保險解決方案。
保險諮詢解決方案("IAS")運營集團通過其覆蓋全國的網絡,整合了全國一些最高質量的獨立保險經紀人,具有廣泛和多樣化的戰略能力和專業知識,爲企業和高淨值個人以及其家庭提供專業設計的商業風險管理、僱員福利和私人風險管理解決方案。
覈保、能力和科技解決方案(「UCTS」)運營團隊包括兩個獨立的業務 —— 其MGA平台(「MSI」)和其新推出的再保券商業務,Juniper Re。通過MSI,該公司生產專有的、科技驅動的保險產品,然後通過風險顧問在其其他運營團隊內部(在許多情況下通過科技和/或API集成)以及通過選擇的分銷合作伙伴,在重點關注其產品提供速度、易用性和執行確定性的庇護頻道,一個例子是通過與物業管理軟件提供商集成銷售的國家內置租戶保險產品。UCTS的批發業務於2024年第一季度出售,其運營業務截至2024年2月29日包含在UCTS的業績中。
Mainstreet 保險方案運營組織(「MIS」)爲社區的個人和商業客戶提供個人保險、商業保險以及人身保險解決方案,重點是通過封閉的分銷渠道接觸客戶,這些渠道包括但不限於新房建築商、房地產經紀人、抵押貸款發起人/放款人、總體規劃社區和其他各種影響社區的中心。MIS運營組也爲政府的援助計劃和解決方案提供諮詢,包括傳統的醫療保險、醫療保險優勢和平價醫療法案,通過主要由獨立承包商代理組成的網絡,向老年人和符合條件的個人提供。
在所有板塊中,公司通過保險放置產生佣金,包括代理賬單和直接賬單安排,並基於潛在業務或績效(如損失率)產生分紅收入。所有板塊還產生其他輔助收入和保費融資收入。
公司在IAS和UCTS運營集團中,通過服務費和諮詢安排獲得收費。已與某些客戶建立了提供保險放置服務的服務費安排。
在UCTS運營集團中,公司通過政策費和分期付款手續費安排收取費用。政策費收入是以MGA身份行事並代表保險公司合作伙伴提供付款處理服務和其他行政職能而獲得的。
24

在MIS運營組中,公司通過與保險公司合作推出聯名Medicare營銷活動獲得營銷收入,並從中獲得佣金和費用。
此外,公司在IAS和UCTS經營組以及公司和其他不可報告部門(「公司和其他」)中產生投資收入。
公司的首席營運決策者,首席執行官,使用淨利潤(損失)以及利息、稅項、折舊、攤銷、和一次性交易相關費用或非經常項目前的淨利潤(損失)來管理資源,並做出業務決策。
公司經營集團的財務摘要信息顯示在以下表格中。公司和其他包括未分配給經營集團的任何費用以及公司相關項目,包括利息費用。經公司和其他部門進行內部結算的相互間營業收入和費用被消除。服務中心費用和其他開銷根據適用於每項費用的營業收入或員工人數分配給公司的經營集團。
公司在2024年9月30日結束的九個月內改變了其運營集團盈利能力的衡量標準。在之前的年份,與公司增長服務同事相關的補償費用主要在企業和其他方面認定。2024年,公司開始在各自的運營集團之間分配增長服務同事的補償。這種度量標準的變化導致在每個運營集團的佣金、僱員薪酬和福利支出增加,而在企業和其他方面減少。
截至2024年9月30日三個月
(以千爲單位)保險諮詢解決方案承保、容量與科技解決方案Mainstreet保險解決方案 公司
和其他
 總計
收入(1)
$159,338 $129,794 $70,658 $(20,852)$338,938 
9,199 13,695 12,399 (49,768)(14,475)

截至2023年9月30日三個月的時間
(以千爲單位)保險諮詢解決方案覈保、容量與科技解決方案主街保險解決方案 企業
和其他
 總計
收入(2)
$148,804 $114,018 $62,297 $(18,849)$306,270 
3,540 11,421 10,763 (57,730)(32,006)

2024年9月30日結束的九個月
(以千爲單位)保險諮詢解決方案覈保、容量及科技解決方案Mainstreet保險解決方案 企業
和其他
 總計
收入(1)
$549,810 $356,176 $209,422 $(56,263)$1,059,145 
55,619 70,470 32,361 (164,692)(6,242)

截止2023年9月30日止九個月
(以千爲單位)保險諮詢解決方案承保、容量與科技解決方案Mainstreet保險解決方案 企業
和其他
 總計
收入(2)
$505,496 $302,662 $174,114 $(48,365)$933,907 
32,798 21,839 22,775 (178,935)(101,523)
__________
(1)    截至2024年9月30日的三個和九個月,UCTS運營集團記錄了同一運營集團內分享的佣金收入$3.6萬美元和10.3 百萬,分別;UCTS運營組記錄了通過其他運營組傳遞的佣金收入$17.9萬美元和46.3 百萬,分別; MIS運營組記錄了同一運營組內分享的佣金收入$0.2萬美元和1.2 百萬,分別。通過同一運營集團分享的佣金收入和通過其他運營集團傳遞的佣金收入將通過企業和其他方式進行清除。
25

(2)    在截至2023年9月30日的三個月和九個月內,UCTS營運集團分別記錄了在同一營運集團內共享的佣金收入$2.7萬美元和8.0 百萬;UCTS營運集團分別記錄了通過其他營運集團傳遞的佣金收入$15.9萬美元和39.7 百萬;MIS營運集團分別記錄了在同一營運集團內共享的佣金收入$0.3萬美元和1.4 百萬;MIS營運集團分別記錄了通過其他營運集團傳遞的佣金收入$
(以千爲單位)保險諮詢解決方案承保、容量與科技解決方案Mainstreet保險解決方案 公司
和其他
 總計
2024年9月30日的總資產
$2,274,647 $630,980 $515,045 $118,368 $3,539,040 
2023年12月31日資產總額
2,292,729 646,404 518,593 44,211 3,501,937 
26

項目2. 管理討論與分析財務狀況和業績
應當結合我們提交給證監會的2024年2月28日提交的「10-Q表格季度報告」以及我們提交給證監會的截至2023年12月31日的年度報告「10-K表格」,閱讀我們財務狀況和經營成果的討論和分析,以及其他地方包含的相關附註和其他財務信息。除了歷史財務信息外,上述討論還包括反映我們計劃、估計和信念的前瞻性陳述。由於各種因素,我們實際的結果可能會與前瞻性陳述中討論的結果有重大不同,包括我們在年度報告「10-K表格」第一部分第1A項「風險因素」中提到的因素。
公司
鮑德溫保險集團股份有限公司是鮑德溫保險集團控股有限責任公司(前身爲鮑德溫風險合作伙伴有限責任公司)的控股公司和唯一管理成員,其唯一的實質性資產是其持有的鮑德溫控股公司的所有權利益,通過這一渠道進行了我們所有的業務。在本第10-Q表格的季度報告中,除非上下文另有說明,「鮑德溫」,「公司」,「我們」,「我們」和「我們」的各個詞條均指的是鮑德溫保險集團股份有限公司,以及其合併子公司,包括鮑德溫控股公司及其合併子公司和關聯公司。
鮑德溫是一家獨立的保險分銷公司,提供不可或缺的專業知識和見解,旨在爲我們的客戶帶來追求目標、激情和夢想的信心。作爲一支敬業的企業家和保險專業人士團隊,我們匯聚在一起,助力保護客戶可能的利益。我們通過提供定製客戶解決方案、服務和創新,通過我們全面而量身定製的風險管理、保險和員工福利方法,來實現這一目標。我們通過部署領先資源和資本,支持客戶、同事、保險公司合作伙伴和社區,推動我們的有機和非有機增長。當我們爲這些關鍵利益相關者持續執行時,我們相信,結果將是爲我們的第五個利益相關者,我們的股東增加價值。我們通過採取整體和定製化的風險管理、保險和員工福利方法,來推動行業創新。我們的增長計劃包括繼續招募、培訓和發展行業領先的人才,繼續通過我們的合作伙伴策略增加地理代表性、保險產品專業知識和最終客戶行業專業知識,以及繼續建設我們的MGA平台(「MSI」),爲我們內部風險顧問和不斷增長的外部分銷合作伙伴提供專有的、技術支持的保險解決方案。我們是一個備受讚譽的文化支持的僱主,由傑出人才驅動,並由行業領先的增長和創新推動。
我們代表美國和國際各地超過兩百萬客戶。我們的4000名同事中包括約700名風險顧問,他們獨立自主,競爭激烈,是"保險極客"。我們在24個州設有約110個辦事處,所有這些辦事處都配備了多樣化的產品和服務,以賦予我們的客戶在每個階段的力量,通過我們的三個運營集團。
保險諮詢解決方案 IAS提供專門設計的商業風險管理、員工福利和個人風險管理解決方案,適用於企業和高淨值個人及其家人。風險管理解決方案通常涉及銷售各種商業和個人保險產品,以減少企業和個人的風險。員工福利解決方案可能包括健康計劃、牙科計劃和退休帳戶,供企業和員工使用。我們很榮幸與全國各地一些最優質的獨立保險經紀人合作,具有廣泛和多樣化的戰略能力和專業知識。我們在整個組織中有意識地認可和提升這種人才,以構建全球一流的行業專業實踐團隊和產品卓越中心,整個公司可以利用。
承保、容量與科技解決方案 (「UCTS」)包括兩個不同的業務——MSI和我們新推出的再保險券商Juniper Re。通過MSI,我們製造專有的、科技驅動的保險產品,然後通過我們的風險顧問在其他經營群體內(在許多情況下通過科技和/或API集成)和通過選擇的分銷合作伙伴進行分發,重點是在我們的產品提供速度、易用性和執行確定性的庇護渠道,一個示例是全國性嵌入式租戶保險產品,通過與物業管理軟件提供商的集成在租賃點出售。作爲公司的主要增長驅動力,我們大量投資於擴大我們的MGA產品組合,目前包括超過20種商業、個人和專業線產品,包括2023年的新產品推出(高淨值業主、洪水和商業地產產品)。UCTS的批發業務在2024年第一季度出售,其運營結果包括在2024年2月底之前。
27

Mainstreet保險解決方案 (「MIS」) 爲個人和企業提供個人保險、商業保險以及生命和健康解決方案,專注通過受保護的分銷渠道,包括但不限於新房建築商、房地產經紀人、抵押貸款發起人/貸款人、總體規劃社區以及其他各種社區影響中心,來爲社區中的個人和企業提供服務。我們在MIS各個領域深入投資,包括在西伍德的住宅解決方案,這些解決方案已嵌入美國許多頂級房屋建築商的產品中,通過我們的全國抵押貸款和房地產中心擴大我們的分銷範圍,以及着重改善顧問和客戶體驗的增強數字能力。Mainstreet Insurance Solutions還爲政府援助計劃和解決方案提供了諮詢服務,包括傳統的醫療保險、醫療優勢計劃和平價醫療法案,以及通過主要獨立承包代理商網絡爲老年人和符合條件個人提供服務。
2011年,我們採納了「方位角」作爲我們的企業和文化憲法。取名自歷史導航工具,用於尋找「真北」,方位角強調我們的核心價值觀、業務基礎和利益相關者承諾。方位角所涵蓋的理念支持我們的使命,即向客戶提供不可或缺的、量身定製的保險和風險管理見解與解決方案。我們努力成爲備受推崇的保險諮詢公司——由人際關係推動,以人爲本,以客戶的採用和忠誠爲例。這種環境是由我們用來描述我們的服務和文化的獨特措辭支撐的。我們是一家公司,而不是一個機構;我們有同事,而不是員工;我們有風險顧問,而不是製作人/經紀人。我們爲客戶服務,而不是顧客,我們將戰略收購稱爲合作伙伴關係。我們稱我們收購的保險經紀公司,或者在資產收購的情況下,所涉製作人,爲合作伙伴。
季節性
保險券商市場具有季節性,我們的營業收入受季節性趨勢的影響。我們的調整後息稅折舊及攤銷前利潤和調整後的息稅折舊及攤銷前利潤率通常在第一季度最高,在第四季度最低。這種變化主要是由於我們營業收入的波動,而財務開支在整年期間保持一致。我們的營業收入通常在第一季度最高,這是由於在某些保險諮詢解決方案和主街保險解決方案業務領域,如員工福利、商業和醫療保險,第一季度保單的投放和續約程度較高。此外,我們第一季度收入中更高比例來自我們利潤最高的業務。
2024年和2023年9月30日結束的三個和九個月的經營業績結果
有關我們財務狀況和經營成果的討論和分析應與我們截至2024年和2023年9月30日的簡明合併財務報表和本報告其他地方包括的相關附註及其他財務信息一起閱讀。
除了歷史財務信息外,以下討論和分析還包含涉及風險、不確定因素和假設的前瞻性聲明。由於許多因素的影響,我們實際的結果和選定事件的時間可能與這些前瞻性聲明中預期的有實質差異,包括在我們截至2023年12月31日止年度的年度報告的第一部分第1A項「風險因素」中討論的那些因素。
28

以下是截至2024年9月30日和2023年的三個和九個月的綜合經營結果討論。
在這三個月裏
9月30日結束
九個月來
9月30日結束
(以千計)20242023方差20242023方差
收入:
佣金和費用$335,210 $304,232 $30,978 $1,050,409 $929,306 $121,103 
投資收益3,728 2,038 1,690 8,736 4,601 4,135 
總收入338,938 306,270 32,668 1,059,145 933,907 125,238 
運營費用:
佣金、員工薪酬和福利247,189 220,469 26,720 753,596 676,659 76,937 
其他運營費用48,839 47,165 1,674 141,198 141,254 (56)
攤銷費用26,899 23,183 3,716 76,334 69,505 6,829 
或有對價公允價值的變化(952)13,914 (14,866)17,276 55,065 (37,789)
折舊費用1,557 1,453 104 4,619 4,250 369 
運營費用總額323,532 306,184 17,348 993,023 946,733 46,290 
營業收入(虧損)15,406 86 15,320 66,122 (12,826)78,948 
其他收入(支出):
利息支出,淨額(31,329)(30,580)(749)(94,203)(87,600)(6,603)
資產剝離的收益1,809 — 1,809 38,953 — 38,953 
債務清償和修改造成的損失(389)— (389)(15,068)— (15,068)
其他收入(支出),淨額28 (1,351)1,379 105 (193)298 
其他支出總額,淨額(29,881)(31,931)2,050 (70,213)(87,793)17,580 
所得稅前虧損
$(14,475)$(31,845)$17,370 $(4,091)$(100,619)$96,528 
佣金和費用全部包括在內的總購買價格
我們通過促成保險公司合作伙伴與客戶之間的安排賺取佣金和費用,以便承運人爲被保險方提供保險。我們的佣金通常是被保險方支付的保費的百分比,一般取決於保險的類型、具體的保險公司合作伙伴和提供的服務性質。在與客戶的某些安排下,我們通過爲保險投放服務賺取預先協商的服務費。此外,我們通過作爲MGA並代表保險公司合作伙伴履行某些行政職能而賺取保單費用,包括交付保單文件、處理支付和其他行政職能。我們還可能收到利潤共享佣金,這代表與承保行爲有關的保險公司合作伙伴支付的可變量形式的考慮。利潤共享佣金通常基於覈保結果,但也可能包含對成交量、增長或續保的考慮。其他收入來源包括其他附帶收入、保費融資收入、以及基於對特定目標醫療保險營銷活動的全面成本報銷而獲得的營銷收入。
佣金和費用在2024年9月30日結束的季度與2023年同期相比增加了3100萬美元,增長了10%,這是由於核心佣金和費用的有機增長達到了3860萬美元,涉及客戶行業領域的新業務和續約業務,並且來自MSI的持續表現超預期,部分抵消了IAS的匯率和敞口下降了(4.7)%。此外,分紅和其他收入本季度增加了210萬美元。這種增長在某種程度上被來源於我們的批發業務的930萬美元的佣金和費用所抵消,該業務是2024年第一季度出售的,並且2024年沒有可比的營業收入。
29

截至2024年9月30日的今年截止目前的時間段,佣金和費用增加了12110萬美元,增長了13%,相比2023年同期,主要由跨客戶行業領域的核心佣金和費用的有機增長所推動,達到了15030萬美元,這與新業務和續保業務有關,並繼續從MSI獲得良好業績。部分抵消此增長的是綜合業務在2023年3月至9月間產生的2130萬美元的佣金和費用,2024年未獲得可比的營收。此外,利潤分享和其他營收在截至目前的時間段減少了540萬美元,主要是2023年期間利潤分享收入強勁,這主要是由於歷史上2023年期間強勁的核保業績和UCTS的時差所致,部分抵銷了MIS的承保風險率改善和銷售保單數量增加。
投資收入
投資收益是通過投資信託持有的資產賺取的。2024年9月30日結束的季度和年初至今期間,與2023年同期相比,投資收益分別增加了170萬美元和410萬美元,這主要歸因於我們現金管理策略的改善和投資現金的收益增長。
佣金、員工薪酬和福利
佣金、員工薪酬和福利是我們最大的開支。它包括(i)基本薪酬,包括支付和應支付給同事的工資、獎金和福利,支付給同事和外部支付給他人的佣金;和(ii)與給予高級管理人員、同事、風險顧問和董事的限制性和無限制性股票獎勵相關的股權激勵。我們預計,隨着預期營業收入增長,我們與同事和風險顧問的薪酬安排中包含巨額獎金或佣金元件,我們的佣金、員工薪酬和福利開銷將繼續普遍上升。此外,我們在人力資本競爭激烈的市場中運營,需要在地理擴張和新產品服務創建過程中保持競爭薪酬水平。
佣金、員工薪酬和福利支出在2024年9月30日結束的季度與2023年同期相比增加了2670萬美元,增長了12%,主要是由於外部佣金的增加,增長了1540萬美元,增長了26%,這是由於UCTS和MIS的增長。此外,員工薪酬增加了540萬美元,這是由於持續投資於支持現有和新產品增長的人員規模,員工考覈激勵增加了430萬美元,這是由於按照合作伙伴的選擇,將相關考覈獎勵義務重新分類爲支付給員工的獎金。
截至2024年9月30日的當年至今期間,佣金、員工薪酬和福利支出增加了7690萬美元,增長11%,與2023年同期相比,主要與外部佣金有關,增加了4740萬美元,增長30%,這主要是由於UCTS和MIS業務的增長。當年至今期間還包括同事獲獎激勵增加1030萬美元,這些與有條件獲得激勵的責任重分類,並根據合作伙伴的選擇,轉爲可支付給同事的獎金。其他增加包括持續投資於支持現有和新產品增長的人員編制,包括890萬美元的福利和其他費用、520萬美元的變動內部佣金以及510萬美元的同事薪酬。
其他營業費用
其他營業費用包括旅行、會計、法律及其他專業費用、招聘費、租金、辦公費用以及與我們業務相關的其他成本。我們與佔用有關的成本和專業服務費用,特別是通常會隨着同事人數以及業務規模的整體大小和規模成比例地增加或減少。
其他營業費用較2023年同期增加了170萬美元,截至2024年9月30日的季度。本季度其他營業費用增加的原因主要是高額法律索賠和和解費用增加了110萬美元,爲了支持我們的增長而支出的旅行和娛樂費用增加了90萬美元,以及與我們品牌重塑相關的廣告和營銷費用增加了90萬美元。這些增加的費用部分被我們實施的某些成本節約措施部分抵銷,其中包括較低的專業費用和房租費用各減少了50萬美元。
30

其他營業費用與2023年同期相比,截至2024年9月30日的本年度至今期間基本持平。由於我們實施了一些成本節約措施,包括重新談判供應商合同、發帖合作伙伴整合帶來的運營效率提高,其他營業費用的幾個類別在本年度至今期間經歷了下降。其中包括較低的專業費用460萬美元,發帖與基礎設施相關費用350萬美元,租金支出80萬美元。這些成本節約部分被300萬美元的更高法律索賠和和解費用、MGA業務的支付處理費200萬美元、執照和稅收150萬美元、支持IAS增長的差旅和娛樂費140萬美元以及與我們的改版相關的廣告和營銷費90萬美元部分抵消。
攤銷費用
截至2024年9月30日的季度和截至目前的年度期間,攤銷費用分別比2023年同期增加370萬美元和680萬美元,主要是由於與IAS內重新品牌有關的商標攤銷加速和與我們的Westwood合作伙伴關係記錄的無形資產較高的攤銷,這些無形資產基於預估經濟利益模式攤銷,部分抵消了2024年第一季度銷售我們的批發業務時的無形資產覈銷相關的攤銷減少。
或有對價公允價值的變化
在2024年9月30日結束的季度內,相關權益交易的變動爲100萬美元的收益,相比之下,2023年同期爲1390萬美元的虧損;截至2024年9月30日的至今期間,相關權益交易的變動爲1730萬美元的虧損,相比之下,2023年同期爲5510萬美元的虧損。截至2024年9月30日結束的季度,由於同事盈利激勵達到了430萬美元,則將作爲選擇權利的夥伴選擇,從待定應計收入責任重新分類爲應支付給同事的獎金,進而導致相關權益交易變動的收益,並增加了佣金、員工薪酬和福利支出。與2024年9月30日結束的至今期間相關的待定應計收入的公允價值虧損受到了某些夥伴收入增長趨勢的積極變化以及接近各自測量日期的待定應計收入義務的遞增的影響,部分抵消了通過重新分類爲同事盈利激勵的1070萬美元的收益認定。
利息支出,淨額
淨利息支出分別在2024年9月30日結束的季度和本年截至當日期間較2023年同期分別增加了70萬美元和660萬美元,這主要是由於平均借款增加,部分被2024年5月的債務再融資導致的較低平均利率抵消。我們預計利息支出在短期內將在同比基礎上保持相對穩定或略有增加。
退出收益
2024年截至9月30日的今年迄今處置業務收益是由於2024年第一季度與出售我們的批發業務有關的3510萬美元的收益推動。
債務滅絕和修改的損失
2024年9月30日止年初至今虧損$1510萬與2024年5月債務再融資有關。
其他收入(費用),淨額
其他收入(費用),淨額,截至2024年9月30日的季度和年初至今期間分別增加了$140萬和$30萬,與相同的2023年期間相比,這主要是由於與在2024年3月到期的利率上限相關的2023年期間承認的損失而驅動的。
31

非GAAP財務指標
調整後的EBITDA、調整後的EBITDA利潤率、有機營業收入、有機營業收入增長、調整後的淨利潤和攤薄後每股收益(「每股收益」),不是根據美國通用會計準則的財務績效指標,不應被視爲美國通用會計準則措施的替代,包括佣金和費用(對於有機營業收入和有機營業收入增長),淨利潤(損失)(對於調整後的EBITDA和調整後的EBITDA利潤率),淨利潤(損失)歸因於鮑德溫(對於調整後的淨利潤)或攤薄後每股收益(損失)(對於調整後的攤薄後每股收益),我們認爲這些是最直接可比較的美國通用會計準則措施。這些非美國通用會計準則財務指標作爲分析工具具有侷限性,在評估我們的運營績效時,您不應將這些非美國通用會計準則財務指標單獨或作爲佣金和費用、淨利潤(損失)、淨利潤(損失)歸因於鮑德溫、攤薄後每股收益或其他根據美國通用會計準則編制的合併損益數據的替代品。我們行業中的其他公司可能會與我們不同定義或計算這些非美國通用會計準則財務指標,因此,這些指標可能與其他公司使用的同名指標不可比較。
我們將調整後的EBITDA定義爲利息、稅款、折舊、攤銷、清償可能責任項下公允價值變動和某些項目的淨利潤(損失),包括按股份報酬支出、與交易有關的合作伙伴和整合費用、人員裁員以及提高資金的相關非經常性項目計算。我們認爲調整後的EBITDA是經營績效的適當指標,因爲它消除了與業務績效無關的收入和費用的影響,並且此指標的呈現增強了投資者對我們財務績效的理解。
調整後的EBITDA利潤率是調整後的EBITDA除以總營業收入。管理層和我們的董事會使用調整後的EBITDA利潤率作爲評估我們的財務表現的關鍵指標。我們認爲調整後的EBITDA利潤率是衡量經營績效的合適指標,因爲它消除了與業務績效無關的收入和支出的影響,並且這一指標的呈現增強了投資者對我們財務表現的理解。我們認爲調整後的EBITDA利潤率有助於衡量以綜合水平運作的盈利能力。
調整後的EBITDA和調整後的EBITDA利潤率作爲分析工具具有重要的侷限性。例如,調整後的EBITDA和調整後的EBITDA利潤率:
不反映因折舊和攤銷而需替換的資產的現金資本支出要求;
不反映我們的營運資本需求的變化或現金需求;
不反映因我們認爲不代表我們持續經營的事項而產生的某些現金費用的影響;
不反映償還我們債務利息或必要的現金要求以償還債務利息或本金支付;
不反映按股進行的補償費用和其他非現金費用;並且
排除某些可能代表我們可用現金減少的稅款支付。
我們根據相關時期從新合作伙伴獲得的首12個月的佣金和費用以及剔除(i)從新合作伙伴產生的首12個月的佣金和費用以及(ii)來自資產剝離的佣金和費用,計算有機營業收入。有機營業收入增速是有機營業收入在時期之間的變化,之前時期的結果被調整以(i)包括在之前時期被排除在有機營業收入之外的佣金和費用,因爲相關合作夥伴尚未達到12個月所有標記,但這些佣金和費用在當前時期已達到12個月所有標記,以及(ii)排除與資產剝離相關的佣金和費用。例如,從2023年6月1日收購的合作伙伴的佣金和費用將從2023年的有機營業收入中排除。然而,在2024年6月1日後,從2023年6月1日到12月31日的這些合作伙伴的結果將與2024年6月1日到12月31日的結果進行比較,以便計算2024年的有機營業收入增長。有機營業收入增長是管理層和我們董事會用來評估我們財務表現的關鍵指標。我們認爲有機營業收入和有機營業收入增長是衡量運營表現的合適指標,因爲它們允許投資者以有意義且一致的方式來衡量、分析和比較增長。
32

We define adjusted net income as net income (loss) attributable to Baldwin adjusted for depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related Partnership and integration expenses, severance, and certain non-recurring costs that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. We believe that adjusted net income is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance.
Adjusted diluted EPS measures our per share earnings excluding certain expenses as discussed above for adjusted net income and assuming all shares of Class B common stock were exchanged for Class A common stock on a one-for-one basis. Adjusted diluted EPS is calculated as adjusted net income divided by adjusted diluted weighted-average shares outstanding. We believe adjusted diluted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods.
Adjusted EBITDA and Adjusted EBITDA Margin
The following table reconciles adjusted EBITDA and adjusted EBITDA margin to net loss, which we consider to be the most directly comparable GAAP financial measure:
For the Three Months
 Ended September 30,
For the Nine Months
 Ended September 30,
(in thousands, except percentages)2024202320242023
Revenues$338,938 $306,270 $1,059,145 $933,907 
Net loss
$(14,475)$(32,006)$(6,242)$(101,523)
Adjustments to net loss:
Interest expense, net31,329 30,580 94,203 87,600 
Amortization expense26,899 23,183 76,334 69,505 
Share-based compensation17,949 14,598 46,764 46,637 
Gain on divestitures(1,809)— (38,953)— 
Change in fair value of contingent consideration(952)13,914 17,276 55,065 
Loss on extinguishment and modification of debt389 — 15,068 — 
Colleague earnout incentives4,327 — 10,706 — 
Transaction-related Partnership and integration expenses2,047 3,774 9,042 18,007 
Depreciation expense1,557 1,453 4,619 4,250 
Severance678 875 3,554 3,373 
Income and other taxes82 161 3,300 904 
Loss on interest rate caps84 818 244 489 
Other(1)
4,646 6,659 13,410 20,289 
Adjusted EBITDA$72,751 $64,009 $249,325 $204,596 
Adjusted EBITDA margin21 %21 %24 %22 %
__________
(1)    Other addbacks to adjusted EBITDA include certain expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.
33

Organic Revenue and Organic Revenue Growth
The following table reconciles organic revenue and organic revenue growth to commissions and fees, which we consider to be the most directly comparable GAAP financial measure:
For the Three Months
 Ended September 30,
For the Nine Months
 Ended September 30,
(in thousands, except percentages)2024202320242023
Commissions and fees
$335,210 $304,232 $1,050,409 $929,306 
Partnership commissions and fees(1)
— (985)— (44,696)
Organic revenue$335,210 $303,247 $1,050,409 $884,610 
Organic revenue growth(2)
$40,672 $47,523 $144,844 $150,471 
Organic revenue growth %(2)
14 %19 %16 %20 %
__________
(1)    Includes the first twelve months of such commissions and fees generated from newly acquired Partners.
(2)    Organic revenue for the three and nine months ended September 30, 2023 used to calculate organic revenue growth for the three and nine months ended September 30, 2024 was $294.5 million and $905.6 million, respectively, which is adjusted to exclude commissions and fees from divestitures that occurred during 2024.
34

Adjusted Net Income and Adjusted Diluted EPS
The following table reconciles adjusted net income to net loss attributable to Baldwin and reconciles adjusted diluted EPS to diluted loss per share, which we consider to be the most directly comparable GAAP financial measures:
For the Three Months
 Ended September 30,
For the Nine Months
 Ended September 30,
(in thousands, except per share data)
2024202320242023
Net loss attributable to Baldwin
$(8,377)$(17,629)$(4,356)$(55,658)
Net loss attributable to noncontrolling interests
(6,098)(14,377)(1,886)(45,865)
Amortization expense26,899 23,183 76,334 69,505 
Share-based compensation17,949 14,598 46,764 46,637 
Gain on divestitures(1,809)— (38,953)— 
Change in fair value of contingent consideration(952)13,914 17,276 55,065 
Loss on extinguishment and modification of debt389 — 15,068 — 
Colleague earnout incentives4,327 — 10,706 — 
Transaction-related Partnership and integration expenses2,047 3,774 9,042 18,007 
Depreciation1,557 1,453 4,619 4,250 
Amortization of deferred financing costs1,422 1,244 4,419 3,577 
Severance678 875 3,554 3,373 
Loss on interest rate caps, net of cash settlements84 3,771 2,544 8,382 
Income tax expense— — 2,151 — 
Other(1)
4,646 6,659 13,410 20,289 
Adjusted pre-tax income42,762 37,465 160,692 127,562 
Adjusted income taxes(2)
4,234 3,709 15,909 12,629 
Adjusted net income$38,528 $33,756 $144,783 $114,933 
Weighted-average shares of Class A common stock outstanding - diluted64,012 60,549 63,001 59,791 
Dilutive weighted-average shares of Class A common stock4,014 3,941 3,570 3,931 
Exchange of Class B common stock(3)
50,490 52,862 51,234 53,367 
Adjusted diluted weighted-average shares outstanding118,516 117,352 117,805 117,089 
Adjusted diluted EPS$0.33 $0.29 $1.23 $0.98 
Diluted loss per share
$(0.13)$(0.29)$(0.07)$(0.93)
Effect of exchange of Class B common stock and net loss attributable to noncontrolling interests per share
0.01 0.02 0.02 0.06 
Other adjustments to loss per share
0.49 0.59 1.42 1.96 
Adjusted income taxes per share(0.04)(0.03)(0.14)(0.11)
Adjusted diluted EPS$0.33 $0.29 $1.23 $0.98 
___________
(1)    Other addbacks to adjusted net income include certain expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.
(2)    Represents corporate income taxes at an assumed effective tax rate of 9.9% applied to adjusted pre-tax income.
(3)    Assumes the full exchange of Class B common stock for Class A common stock pursuant to the Amended LLC Agreement.

35


INSURANCE ADVISORY SOLUTIONS OPERATING GROUP RESULTS
IAS provides expertly-designed commercial risk management, employee benefits and private risk management solutions for businesses and high-net-worth individuals, as well as their families, through our national footprint, which has assimilated some of the highest quality independent insurance brokers in the country with vast and varied strategic capabilities and expertise.
Effective January 1, 2024, our FounderShield Partner moved from UCTS to IAS. Prior year results of operations for IAS below have been recast to conform to the current organizational structure.
For the Three Months
 Ended September 30,
VarianceFor the Nine Months
 Ended September 30,
Variance
(in thousands, except percentages)20242023Amount%20242023Amount%
Revenues:
Commissions and fees
$157,535 $147,523 $10,012 %$545,384 $502,991 $42,393 %
Investment income
1,803 1,281 522 41 %4,426 2,505 1,921 77 %
Total revenues
159,338 148,804 10,534 %549,810 505,496 44,314 %
Operating expenses:
Commissions, employee compensation and benefits
119,266 103,639 15,627 15 %383,086 335,289 47,797 14 %
Other operating expenses
20,098 19,867 231 %59,328 59,809 (481)(1)%
Amortization expense
16,435 13,447 2,988 22 %46,087 40,338 5,749 14 %
Change in fair value of contingent consideration
(4,195)7,882 (12,077)(153)%9,709 36,095 (26,386)(73)%
Depreciation expense
363 388 (25)(6)%1,094 1,155 (61)(5)%
Total operating expenses
151,967 145,223 6,744 %499,304 472,686 26,618 %
Operating income
7,371 3,581 3,790 106 %50,506 32,810 17,696 54 %
Total other income (expense)
1,828 (167)1,995 n/m5,138 (12)5,150 n/m
Income before income taxes$9,199 $3,414 $5,785 169 %$55,644 $32,798 $22,846 70 %
__________
n/m    not meaningful
Commissions and Fees
IAS generates (i) commissions for placing insurance policies on behalf of its Insurance Company Partners; (ii) profit-sharing income based on either the underlying book of business or performance, such as loss ratios; and (iii) fees from consulting and service fee arrangements, which are in place with certain Clients for a negotiated fee.
IAS commissions and fees increased $10.0 million for the quarter ended September 30, 2024 compared to the same period of 2023, due to higher core commissions and fees, which grew organically by 6%. Growth in our core commissions and fees was driven by 22% sales velocity (new business as a percentage of prior year commissions and fees) and resultant new business across Client industry sectors. Sales velocity for the quarter improved 400 bps over the same period of 2023 despite softness in our construction practice. New business growth was offset in part by rate and exposure of (4.7)% resulting from construction project work weakness and headwinds concentrated in our employee benefits practice. In addition, profit-sharing revenue increased $2.4 million for the quarter.
IAS commissions and fees increased $42.4 million for the year-to-date period ended September 30, 2024 compared to the same period of 2023, due to organic growth in core commissions and fees of 10%. Growth in our core commissions and fees was driven by 21% sales velocity, which improved 430 bps over the prior-year period, and resultant new business across Client industry sectors. New business growth was offset in part by rate and exposure headwinds of (1.0)% attributable largely to our real estate book, particularly catastrophe-exposed real estate, employee benefits practice, and construction project work weakness. In addition, profit-sharing revenue increased $1.5 million for the year-to-date period.
36


Investment Income
IAS investment income increased $0.5 million and $1.9 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, due to improvements in our cash management strategy and growing yield on our invested cash.
Commissions, Employee Compensation and Benefits
Commissions, employee compensation and benefits expense for IAS increased $15.6 million and $47.8 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, primarily due to an increase in Colleague compensation of $10.2 million and $25.1 million, respectively, driven by continued investments in headcount to support our growth, coupled with an increase in Colleague compensation allocated to IAS that was previously recognized in Corporate and Other. The quarter and year-to-date periods also included increases related to Colleague earnout incentives of $4.3 million and $10.3 million, respectively, for contingent earnout liabilities that were reclassified, at the Partner's option, to a bonus payable to Colleagues. In addition, variable inside commissions increased $8.0 million, or 7%, during the year-to-date period, in line with the growth in IAS’ core commissions and fees.
Other Operating Expenses
Other operating expenses for IAS were relatively flat for each of the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023. Other operating expenses for the year-to-date period included higher costs for legal claims and settlement expense of $1.9 million and travel and entertainment of $1.8 million to support the growth in IAS, which were offset in part by $1.8 million of cost savings from measures we have implemented, including the renegotiation of vendor contracts and post Partnership integration operational efficiencies gained, and a reduction in professional fees of $1.1 million.
Amortization Expense
IAS amortization expense increased $3.0 million and $5.7 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, due to the acceleration of trade names amortization in connection with rebranding within IAS.
Change in Fair Value of Contingent Consideration
Change in fair value of contingent consideration for IAS was a $4.2 million gain for the quarter ended September 30, 2024 compared to a $7.9 million loss for the same period of 2023, and a $9.7 million loss for the year-to-date period ended September 30, 2024 compared to a $36.1 million loss for the same period of 2023. The fair value gain for the quarter ended September 30, 2024 was impacted by Colleague earnout incentives of $4.3 million, which were reclassified, at the Partner's option, from contingent earnout liabilities to a bonus payable to Colleagues, thereby resulting in a gain in the change in fair value of contingent consideration and an increase to commissions, employee compensation and benefits expense. The fair value loss related to contingent consideration for the year-to-date period ended September 30, 2024 was impacted by positive changes in revenue growth trends of certain partners, offset in part by a gain recognized in connection with the reclassification of $10.7 million to Colleague earnout incentives.
UNDERWRITING, CAPACITY & TECHNOLOGY SOLUTIONS OPERATING GROUP RESULTS
UCTS consists of two distinct businesses—MSI and our newly launched reinsurance brokerage business, Juniper Re. Through MSI, we manufacture proprietary, technology-enabled insurance products with a focus on sheltered channels where our products deliver speed, ease of use and certainty of execution, an example of which is our national embedded renters insurance product sold at point of lease via integrations with property management software providers. Our MGA product suite is now comprised of more than 20 products across personal, commercial and professional lines. UCTS’ Wholesale Business was sold in the first quarter of 2024 and its operations are included in our results through February 29, 2024.
Effective January 1, 2024, our FounderShield Partner moved from UCTS to IAS. Prior year results of operations for UCTS below have been recast to conform to the current organizational structure.
37


For the Three Months
 Ended September 30,
VarianceFor the Nine Months
 Ended September 30,
Variance
(in thousands, except percentages)20242023Amount%20242023Amount%
Revenues:
Commissions and fees
$128,718 $113,313 $15,405 14 %$353,373 $301,357 $52,016 17 %
Investment income
1,076 705 371 53 %2,803 1,305 1,498 115 %
Total revenues
129,794 114,018 15,776 14 %356,176 302,662 53,514 18 %
Operating expenses:
Commissions, employee compensation and benefits
98,037 82,593 15,444 19 %268,818 220,999 47,819 22 %
Other operating expenses
11,086 10,308 778 %32,473 30,537 1,936 %
Amortization expense
3,850 3,999 (149)(4)%10,730 11,965 (1,235)(10)%
Change in fair value of contingent consideration
3,032 5,538 (2,506)(45)%7,355 17,681 (10,326)(58)%
Depreciation expense
151 159 (8)(5)%463 460 %
Total operating expenses
116,156 102,597 13,559 13 %319,839 281,642 38,197 14 %
Operating income
13,638 11,421 2,217 19 %36,337 21,020 15,317 73 %
Total other income, net
57 — 57 n/m34,133 819 33,314 n/m
Income before income taxes$13,695 $11,421 $2,274 20 %$70,470 $21,839 $48,631 n/m
__________
n/m    not meaningful
Commissions and Fees
UCTS generates (i) commissions for underwriting and placing insurance policies on behalf of its Insurance Company Partners; (ii) policy fee and installment fee revenue for acting in the capacity of an MGA and fulfilling certain administrative functions on behalf of Insurance Company Partners, including delivery of policy documents, processing payments and other administrative functions; (iii) profit-sharing income, generally based on the profitability of the underlying book of business of the policies it generates on behalf of its Insurance Company Partners; and (iv) fees from service fee arrangements, which are in place with certain customers for a negotiated fee.
UCTS commissions and fees increased $15.4 million and $52.0 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, due to higher core commissions and fees, which grew organically by 31% and 36% for the comparative periods, respectively. Growth in our core commissions and fees was driven by continued outperformance in our multi-family business (accounting for $10.9 million and $29.3 million of the quarter and year-to-date increases in core commissions and fees, respectively), momentum in our homeowners (accounting for $8.9 million and $27.5 million of the quarter and year-to-date increases in core commissions and fees, respectively) and commercial umbrella products (accounting for $2.2 million and $9.8 million of the of the quarter and year-to-date increases in core commissions and fees, respectively), and growing contribution from our reinsurance brokerage business and commercial property program. These increases were partially offset by reductions in profit-sharing revenue for each of the periods, which is primarily a function of strong profit sharing revenue in the 2023 periods, driven by both historically strong underwriting performance in the 2023 periods and timing differences. In addition, our Wholesale Business, which was sold in the first quarter of 2023, generated $9.3 million of commissions and fees during the third quarter of 2023 and $21.3 million of commissions and fees between March and September of 2023, for which there were no comparable revenues earned in 2024.
The initial term for the QBE Program Administrator Agreement expires in May of 2025, but has an extended term through May of 2027 during which MSI is required to assist QBE in arranging adequate reinsurance covering the business to be written between May 2025 and May 2027. The Company is currently working to assist QBE in arranging the reinsurance required to extend the QBE Program Administrator Agreement through May 2027.
Investment Income
UCTS investment income increased $0.4 million and $1.5 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, due to improvements in our cash management strategy and growing yield on our invested cash.
38


Commissions, Employee Compensation and Benefits
Commissions, employee compensation and benefits expense for UCTS includes both outside commissions paid to partners that distribute our MGA products and compensation paid to Colleagues. Commissions, employee compensation and benefits expense for UCTS increased $15.4 million and $47.8 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, primarily driven by outside commissions, which increased $13.9 million, or 23%, for the quarter, and $40.3 million, or 26%, for the year-to-date period, in line with the growth in UCTS’ core commissions and fees. The year-to-date period also included increases in benefits and other expense of $5.0 million and Colleague compensation of $4.8 million, driven by continued investments in headcount to support the growth of existing and new products, coupled with an increase in Colleague compensation allocated to UCTS that was previously recognized in Corporate and Other.
Other Operating Expenses
Other operating expenses for UCTS increased $0.8 million and $1.9 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively. The increase in other operating expenses for the year-to-date period was driven by higher costs due to fulfilling certain administrative functions on behalf of Insurance Company Partners (including an increase in payment processing fees) of $2.9 million, generally higher costs to support the growth of the business and the launch of new products of $1.8 million, travel and entertainment of $0.8 million to support our growth, and legal claims and settlement expense of $0.7 million. These increases were offset in part by reductions in Partnership integration expenses of $2.9 million and professional fees of $1.3 million.
Amortization Expense
UCTS amortization expense decreased $0.1 million and $1.2 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, primarily due to the write-off of intangible assets in connection with the sale of our Wholesale Business during the first quarter of 2024.
Change in Fair Value of Contingent Consideration
Change in fair value of contingent consideration for UCTS was a $3.0 million loss for the quarter ended September 30, 2024 compared to a $5.5 million loss for the same period of 2023, and a $7.4 million loss for the year-to-date period ended September 30, 2024 compared to a $17.7 million loss for the same period of 2023. The fair value losses related to contingent consideration for 2024 were impacted by positive changes in revenue growth trends of certain partners and accretion of the contingent earnout obligations approaching their respective measurement dates.
Total Other Income
Total other income for UCTS of $34.1 million for the year-to-date period ended September 30, 2024 was driven by a $35.1 million gain recorded in connection with the sale of our Wholesale Business during the first quarter of 2024.
39


MAINSTREET INSURANCE SOLUTIONS OPERATING GROUP RESULTS
MIS offers personal insurance, commercial insurance, and life and health solutions to individuals and businesses in their communities, with a focus on accessing clients via sheltered distribution channels, which include, but are not limited to, new home builders, realtors, mortgage originators/lenders, master planned communities, and various other community centers of influence. MIS also offers consultation for government assistance programs and solutions, including traditional Medicare, Medicare Advantage and Affordable Care Act, to seniors and eligible individuals through a network of primarily independent contractor agents.
For the Three Months
 Ended September 30,
VarianceFor the Nine Months
 Ended September 30,
Variance
(in thousands, except percentages)20242023Amount%20242023Amount%
Revenues:
Commissions and fees
$70,658 $62,297 $8,361 13 %$209,422 $174,114 $35,308 20 %
Operating expenses:
Commissions, employee compensation and benefits
42,372 37,536 4,836 13 %131,603 109,257 22,346 20 %
Other operating expenses
9,123 7,769 1,354 17 %25,765 23,243 2,522 11 %
Amortization expense
6,368 5,701 667 12 %18,945 17,160 1,785 10 %
Change in fair value of contingent consideration
211 494 (283)(57)%212 1,289 (1,077)(84)%
Depreciation expense
190 151 39 26 %528 419 109 26 %
Total operating expenses
58,264 51,651 6,613 13 %177,053 151,368 25,685 17 %
Operating income
12,394 10,646 1,748 16 %32,369 22,746 9,623 42 %
Total other income (expense), net(13)17 (131)%29 (27)(93)%
Income before income taxes$12,398 $10,633 $1,765 17 %$32,371 $22,775 $9,596 42 %
Commissions and Fees
MIS generates (i) commissions for placing insurance policies on behalf of its Insurance Company Partners; (ii) profit-sharing income based on either the underlying book of business or performance, such as loss ratios; and (iii) commissions and fees in the form of marketing income, which is earned through co-branded marketing campaigns with our Insurance Company Partners.
MIS commissions and fees increased $8.4 million and $35.3 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, due to higher core commissions and fees, which grew organically by $6.2 million, or 11%, for the quarter, and $31.4 million, or 20%, for the year-to-date period. Key drivers of the organic growth in MIS core commissions and fees included our Westwood Partner (accounting for $3.2 million and $15.8 million of the quarter and year-to-date increases in core commissions and fees, respectively), our legacy Mainstreet business (accounting for $2.5 million and $12.0 million of the quarter and year-to-date increases in core commissions and fees, respectively), and the national mortgage and real estate channel (accounting for $0.5 million and $3.6 million of the quarter and year-to-date increases in core commissions and fees, respectively). In addition, MIS profit-sharing and other revenue increased $2.2 million and $4.1 million for the quarter and year-to-date periods, respectively, primarily resulting from improvements in loss ratios and the number of policies sold.
Commissions, Employee Compensation and Benefits
Commissions, employee compensation and benefits expense for MIS increased $4.8 million and $22.3 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, primarily due to outside commissions, which increased $3.2 million, or 20%, for the quarter, and $12.8 million, or 28%, for the year-to-date period, relating to growth in our Westwood and legacy Mainstreet businesses. The quarter and year-to-date periods also included higher Colleague compensation of $0.7 million and $6.1 million, respectively, driven by continued investments in headcount to support our growth, coupled with an increase in Colleague compensation allocated to MIS that was previously recognized in Corporate and Other.
40


Other Operating Expenses
Other operating expenses for MIS increased $1.4 million and $2.5 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively. The increase in other operating expenses for the quarter and year-to-date periods was driven by higher technology-related costs to support the growth of the business of $0.3 million and $0.9 million, respectively, licenses and taxes of $0.2 million and $0.5 million, respectively, travel and entertainment of $0.2 million and $0.4 million, respectively, and advertising and marketing of $0.4 million and $0.1 million, respectively.
Amortization Expense
MIS amortization expense increased $0.7 million and $1.8 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, primarily driven by higher amortization of intangible assets recorded in connection with our Westwood Partnership, which are amortized based on a pattern of estimated economic benefit.
CORPORATE AND OTHER RESULTS
For the Three Months
 Ended September 30,
VarianceFor the Nine Months
 Ended September 30,
Variance
(in thousands, except percentages)20242023Amount%20242023Amount%
Revenues:
Commissions and fees
$(21,701)$(18,901)$(2,800)15 %$(57,770)$(49,156)$(8,614)18 %
Investment income
849 52 797 n/m1,507 791 716 91 %
Total revenues
(20,852)(18,849)(2,003)11 %(56,263)(48,365)(7,898)16 %
Operating expenses:
Commissions, employee compensation and benefits
(12,486)(3,299)(9,187)n/m(29,911)11,114 (41,025)n/m
Other operating expenses
8,532 9,221 (689)(7)%23,632 27,665 (4,033)(15)%
Amortization expense
246 36 210 n/m572 42 530 n/m
Depreciation expense
853 755 98 13 %2,534 2,216 318 14 %
Total operating expenses
(2,855)6,713 (9,568)(143)%(3,173)41,037 (44,210)(108)%
Operating loss
(17,997)(25,562)7,565 (30)%(53,090)(89,402)36,312 (41)%
Other expense:
Interest expense, net
(31,346)(30,574)(772)%(94,230)(87,781)(6,449)%
Loss on extinguishment and modification of debt(389)— (389)n/m(15,068)— (15,068)n/m
Other expense, net
(35)(1,177)1,142 (97)%(188)(848)660 (78)%
Total other expense, net(31,770)(31,751)(19)— %(109,486)(88,629)(20,857)24 %
Loss before income taxes$(49,767)$(57,313)$7,546 (13)%$(162,576)$(178,031)$15,455 (9)%
__________
n/m    not meaningful
Commissions and Fees
Corporate and Other records the elimination of intercompany commissions revenue from the Operating Groups. During the quarter and year-to-date periods ended September 30, 2024, UCTS recorded commissions revenue shared within the same Operating Group of $3.6 million and $10.3 million, respectively; UCTS recorded commissions revenue passed through to other Operating Groups of $17.9 million and $46.3 million, respectively; and MIS recorded commissions revenue shared within the same Operating Group of $0.2 million and $1.2 million, respectively.
A substantial portion of the intercompany commissions revenue recorded during the year-to-date period is related to the QBE Program Administrator Agreement. We expect intercompany commissions revenue to continue to grow as we serve as the MGA on more intersegment revenue such as homeowners insurance sold through MIS.
41


Commissions, Employee Compensation and Benefits
Commissions, employee compensation and benefits expense in Corporate and Other decreased $9.2 million and $41.0 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, driven by a reduction in Colleague compensation of $7.3 million and $30.9 million, respectively, due in part to a decrease in corporate-related headcount, including the retirement of two of our executive officers at the end of 2023, coupled with a decrease in Colleague compensation previously recognized in Corporate and Other that is now allocated to the Operating Groups. In addition, intercompany commissions expense eliminations increased $2.8 million and $8.6 million for the quarter and year-to-date periods, respectively.
A significant portion of the year-over-year increase in intercompany commissions expense eliminated through Corporate and Other is related to the QBE Program Administrator Agreement. We expect intercompany commissions expense to continue to grow as we serve as the MGA on more intersegment revenue such as homeowners insurance sold through MIS.
Other Operating Expenses
Other operating expenses in Corporate and Other decreased $0.7 million for the quarter ended September 30, 2024 compared to the same period of 2023 due, in part, to certain cost saving measures we have implemented, including the renegotiation of vendor contracts, and operational efficiencies gained from Partnership integration projects by our Operating Groups during 2023, offset in part by higher costs incurred in connection with our rebranding.
Other operating expenses in Corporate and Other decreased $4.0 million for the year-to-date period ended September 30, 2024 compared to the same period of 2023 due to reductions in professional fees of $2.2 million, travel and entertainment of $1.6 million, infrastructure-related costs of $1.2 million and rent expense of $0.7 million. These cost savings are due, in part, to certain cost saving measures we have implemented, including the renegotiation of vendor contracts, and operational efficiencies gained from Partnership integration projects by our Operating Groups. These decreases were offset in part by higher licenses and taxes expense of $1.0 million and higher advertising and marketing costs of $0.7 million connected to our rebranding.
Interest Expense, Net
Interest expense, net, in Corporate and Other increased $0.8 million and $6.4 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, resulting from higher average borrowings, offset in part by lower average interest rates resulting from the May 2024 debt refinancing. We expect interest expense to remain relatively flat or increase slightly in the near-term on a year-over-year basis.
Loss on Extinguishment and Modification of Debt
Loss on extinguishment and modification of debt in Corporate and Other of $15.1 million for the year-to-date period ended September 30, 2024 relates to the May 2024 debt refinancing.
Other Expense, Net
Other expense, net, in Corporate and Other decreased $1.1 million and $0.7 million for the quarter and year-to-date periods ended September 30, 2024 compared to the same periods of 2023, respectively, driven by losses recognized on interest rate caps during the 2023 periods in connection with an interest rate cap that expired in March 2024.
LIQUIDITY AND CAPITAL RESOURCES
Our primary liquidity needs for the foreseeable future will include cash to (i) provide capital to facilitate the organic growth of our business and to fund future Partnerships, (ii) pay operating expenses, including cash compensation to our Colleagues and expenses related to being a public company, (iii) make payments under the Tax Receivable Agreement, (iv) pay interest and principal due on borrowings under the 2024 Credit Facility and the Senior Secured Notes, (v) pay contingent earnout liabilities, (vi) pay income taxes, and (vii) fund potential investments in third party businesses that support the growth of our business, which may include Emerald Bay or sponsorship of, and a minority, non-controlling interest in, other investment funds, the purpose of which may include facilitating the establishment of additional and alternative capacity that supports the growth of our MSI business.
We have historically financed our operations and funded our debt service through the sale of our insurance products and services, and we have financed significant cash needs to fund growth through the acquisition of Partners through debt and equity financing.
42


On May 24, 2024, we repaid in full our then-outstanding debt with proceeds from an offering of $600 million in aggregate principal amount of 7.125% senior secured notes due May 15, 2031 (the “Senior Secured Notes”) and borrowings under a new $840 million senior secured first lien term loan facility maturing May 24, 2031 (the “2024 Term Loan”). In connection with the refinancing, we also established a new senior secured first lien revolving facility with commitments in an aggregate principal amount of $600 million maturing May 24, 2029 (the “2024 Revolving Facility” and, together with the 2024 Term Loan, the “2024 Credit Facility”). Proceeds from the issuance of the Senior Secured Notes and the 2024 Term Loan were also used to pay related fees, costs, expenses and accrued interest. Refer to Note 8 to our condensed consolidated financial statements included in Part I, Item 1. Financial Statements of this report for more information relating to the terms of the Senior Secured Notes and 2024 Credit Facility.
In the near term, we intend to fund our earnout obligations with cash and cash equivalents, including unused proceeds from the issuance of the Senior Secured Notes and the 2024 Term Loan, cash flow from operations and available borrowings under the 2024 Revolving Facility. From time to time, we will consider raising additional debt or equity financing if and as necessary to support our growth, including in connection with the exploration of Partnership opportunities or to refinance existing obligations on an opportunistic basis.
As of September 30, 2024, our cash and cash equivalents were $181.8 million and we had $600.0 million of available borrowing capacity on the 2024 Revolving Facility. We believe that our cash and cash equivalents, cash flow from operations and available borrowings will be sufficient to fund our working capital and meet our commitments for the next twelve months and beyond.
Contractual Obligations and Commitments
The following table represents our contractual obligations and commitments, aggregated by type, at September 30, 2024:
Payments Due by Period
(in thousands)TotalLess than
1 year
1-3 years3-5 yearsMore than
5 years
Operating leases(1)
$99,401 $21,801 $38,964 $28,792 $9,844 
Debt obligations payable(2)
2,173,106 118,167 235,243 232,523 1,587,173 
Undiscounted estimated contingent earnout obligation(3)
205,217 202,005 3,212 — — 
USF Grant4,200 848 1,720 1,632 — 
Total$2,481,924 $342,821 $279,139 $262,947 $1,597,017 
__________
(1)    Represents noncancelable operating leases for our facilities. Operating lease expense was $16.2 million and $16.8 million for the nine months ended September 30, 2024 and 2023, respectively.
(2)    Represents scheduled debt obligations and estimated interest payments for our Senior Secured Notes and 2024 Term Loan.
(3)    Represents the total expected future payments to be made to Partners at September 30, 2024.
Our contractual obligations and commitments are comprised of operating lease obligations, principal and interest payments on our borrowings under the Senior Secured Notes and the 2024 Term Loan, estimated payments of contingent earnout liabilities and our commitment to the University of South Florida (“USF”).
Our operating lease obligations represent noncancelable agreements for our corporate headquarters and office space for our insurance brokerage business. Our operating lease agreements expire through March 2032. These obligations do not include leases with an initial term of twelve months or less, which are expensed as incurred. We may extend, terminate or otherwise modify or sub-lease facilities as needed to best suit the needs of our business. The lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised.
Our debt obligations at September 30, 2024 include borrowings outstanding under the Senior Secured Notes of $600 million and the 2024 Term Loan of $837.9 million. Estimated interest payments for outstanding borrowings on the Senior Secured Notes and 2024 Term Loan in the table above were calculated based on the applicable interest rates at September 30, 2024 of 7.125% and 8.10%, respectively, through their respective due dates of May 15, 2031 and May 24, 2031.
43


Substantially all of our Partnerships and certain acquisitions of select books of business that do not constitute a complete business enterprise include contractual earnout provisions. We record an estimation of the fair value of the contingent earnout obligations at the Partnership date as a component of the consideration paid. Our contingent earnout obligations are measured at fair value each reporting period based on the present value of the expected future payments to be made to Partners in accordance with the provisions outlined in the respective purchase agreements. The recorded obligations are based on estimates of the Partners’ future performance using financial projections for the earnout period. The aggregate estimated contingent earnout liabilities included on our condensed consolidated balance sheet at September 30, 2024 was $203.8 million, of which $4.5 million must be settled in cash and the remaining $199.3 million can be settled in cash or stock at our option. The undiscounted estimated contingent earnout obligation presented in the table above represents the total expected future payments to be made to the Partners. The undiscounted estimated contingent earnout obligation at September 30, 2024 was $205.2 million, of which $5.0 million must be settled in cash and the remaining $200.2 million can be settled in cash or stock at our option. The maximum estimated exposure to the contingent earnout liabilities was $329.2 million at September 30, 2024.
As of September 30, 2024, we have a remaining commitment to USF to donate $4.2 million through October 2028. The gift will provide support for the School of Risk Management and Insurance in the USF Muma College of Business. It is currently anticipated that Lowry Baldwin, our Chairman, will fund half of this commitment.
Tax Receivable Agreement
We expect to obtain an increase in our share of the tax basis in the assets of Baldwin Holdings when its LLC Units are redeemed or exchanged for shares of Baldwin’s Class A common stock. This increase in tax basis may have the effect of reducing the future amounts paid to various tax authorities. The increase in tax basis may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets.
We have a Tax Receivable Agreement that provides for the payment by us to the parties to the Tax Receivable Agreement of 85% of the amount of cash savings, if any, in U.S. federal, state and local income tax or franchise tax that we actually realize as a result of (i) any increase in tax basis in Baldwin’s assets and (ii) tax benefits related to imputed interest deemed arising as a result of payments made under the tax receivable agreement.
During the nine months ended September 30, 2024, we redeemed 2,408,931 LLC Units of Baldwin Holdings on a one-for-one basis for shares of Class A common stock and cancelled the corresponding shares of Class B common stock. We receive an increase in our share of the tax basis in the net assets of Baldwin Holdings due to the interests being redeemed. We have assessed the realizability of the net deferred tax assets and in that analysis have considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. We have recorded a full valuation allowance against the deferred tax assets at Baldwin as of September 30, 2024, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances.
Sources and Uses of Cash
The following table summarizes our cash flows from operating, investing and financing activities for the periods indicated:
For the Nine Months
 Ended September 30,
(in thousands)20242023Variance
Net cash provided by operating activities$85,708 $22,799 $62,909 
Net cash provided by (used in) investing activities25,609 (16,948)42,557 
Net cash provided by (used in) financing activities6,436 (41,928)48,364 
Net increase (decrease) in cash and cash equivalents and restricted cash117,753 (36,077)153,830 
Cash and cash equivalents and restricted cash at beginning of period226,963 230,471 (3,508)
Cash and cash equivalents and restricted cash at end of period$344,716 $194,394 $150,322 
Operating Activities
The primary sources and uses of cash for operating activities are net income (loss) adjusted for non-cash items and changes in assets and liabilities, or operating working capital, and payment of contingent earnout consideration. Net cash provided by operating activities increased $62.9 million year over year, driven by an increase in cash related to the change in premiums, commissions and fees receivable, net of accounts payable, accrued expenses and other current liabilities of $38.2 million relating to holding fiduciary cash on behalf of our insurance company partners, and better operating leverage year over year.
44


Investing Activities
The primary sources and uses of cash for investing activities relate to cash consideration paid to fund Partnerships and other investments to grow our business. Net cash provided by investing activities increased $42.6 million year over year driven by cash proceeds from divestitures, net of cash transferred of $57.0 million, relating primarily to the sale of our Wholesale Business during 2024, offset in part by a decrease in cash relating to higher capital expenditures of $14.7 million due to software development projects.
Financing Activities
The primary sources and uses of cash for financing activities relate to the issuance of our Class A common stock; debt servicing costs in connection with our long-term debt and revolving line of credit, as well as purchases, sales and settlements of interest rate caps to mitigate interest rate volatility on that debt; payment of contingent earnout consideration; and other equity transactions. Net cash provided by financing activities increased $48.4 million year over year driven by an increase in net proceeds from borrowings on our credit facilities of $102.4 million resulting from the May 2024 debt refinancing, inclusive of the deferred financing costs incurred, offset in part by a decrease in cash from additional payments of contingent earnout consideration classified as financing activity of $37.9 million, an increase in tax distributions to Baldwin Holdings members of $10.7 million relating to the sale of our Wholesale Business during 2024, and fewer cash settlements from interest rate caps of $5.6 million.
CRITICAL ACCOUNTING ESTIMATES
Our consolidated financial statements are prepared in accordance with GAAP, which requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Our estimates, judgments and assumptions are continually evaluated based on historical experience, known or expected trends, independent valuations and other factors we believe to be reasonable under the circumstances. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.
There have been no material changes in our critical accounting policies during the nine months ended September 30, 2024 as compared to those disclosed in the Critical Accounting Policies and Estimates section under Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2023.
RECENT ACCOUNTING PRONOUNCEMENTS
Please refer to Note 1 to our condensed consolidated financial statements included in Part I, Item 1. Financial Statements of this report for a discussion of recent accounting pronouncements that may impact us.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Market risk is the potential loss arising from adverse changes in market rates and prices, such as premium amounts, interest rates and equity prices. We are exposed to market risk through our investments and borrowings under the 2024 Credit Facility. We use derivative instruments to mitigate our risk related to the effect of rising interest rates on our cash flows. However, we do not use derivative instruments for trading or speculative purposes.
Our invested assets are held primarily as cash and cash equivalents and restricted cash. To a lesser extent, we may also utilize certificates of deposit, U.S. treasury securities and professionally managed short duration fixed income funds. These investments are subject to market risk. The fair value of our invested assets at September 30, 2024 and December 31, 2023 approximated their respective carrying values due to their short-term duration and therefore, such market risk is not considered to be material.
At September 30, 2024, we had $837.9 million of borrowings outstanding under the 2024 Term Loan and no outstanding borrowings under our 2024 Revolving Facility. The 2024 Term Loan bears interest based on a variable rate of term SOFR, plus an applicable margin of 325 bps. An increase of 100 basis points on the term SOFR rate at September 30, 2024 would have increased our annual interest expense for the 2024 Credit Facility by $8.4 million.
Other than the entry into the 2024 Credit Facility and the expiration of our $300.0 million notional, 1.50% interest rate cap on March 10, 2024, there have been no material changes in market risk from the information presented in Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2023.
45


ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2024 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our senior management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosures.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2024, which were identified in connection with management’s evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.
46


PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Please refer to Note 13 to our condensed consolidated financial statements included in Part I, Item 1. Financial Statements of this report for a discussion of legal proceedings to which the Company is subject.
ITEM 1A. RISK FACTORS
See the risk factors outlined under Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 28, 2024.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Sales of Unregistered Securities
None.
Issuer Repurchases of Equity Securities
The following table provides information about our repurchase of shares of our Class A common stock during the three months ended September 30, 2024:
Total Number of Shares Purchased(1)
Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Value that may yet be Purchased under the Plans or Programs
July 1, 2024 to July 31, 202448,517 $37.37 — $— 
August 1, 2024 to August 31, 202428,690 41.63 — — 
September 1, 2024 to September 30, 20243,227 46.00 — — 
Total80,434 $39.24 — $— 
__________
(1)    We purchased 80,434 shares during the three months ended September 30, 2024, which were acquired from our employees to cover required tax withholding on the vesting of shares granted under our Omnibus Incentive Plan or Partnership Inducement Award Plan.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
Insider Trading Arrangements and Policies
During the quarter ended September 30, 2024, none of our directors or officers adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K).
Adoption of Executive Severance Plan
On October 30, 2024, upon the recommendation of its Compensation Committee, the Board of Directors of the Company adopted and approved The Baldwin Insurance Group Holdings, LLC Executive Severance and Change in Control Benefit Program (the “Severance Plan”), effective November 1, 2024. The Severance Plan provides severance benefits to the Company’s executive officers and certain other eligible employees in the event of certain terminations of their employment and in connection with a Change in Control (as defined in the Severance Plan).
47


Retirement
Subject to the executive’s execution of a general release of liability in favor of the Company and compliance with the terms of a restrictive covenant agreement for five years following the retirement date, the Plan provides for retirement benefits to a retiring participant who either (i) is at least 50 years of age with more than 10 years of service to the Company, or (ii) has been continuously employed with the Company since its October 2019 initial public offering, including:
payment of any earned but unpaid bonus under the Company’s annual incentive plan (“AIP”) for the completed prior year if the retirement date occurs prior to the scheduled date of the payment for such bonus;
a portion of the retiring executive’s AIP payment for the year in which retirement occurs, determined in accordance with the applicable criteria under the AIP (assuming the “Target” threshold was achieved) and pro-rated for the time in the executive’s role for such year; and
continued vesting of time-based and performance-based equity awards granted to the executive under the Company’s Omnibus Incentive Plan.
Qualifying Separation from Service With No Change in Control
The Severance Plan provides for the payment of severance and other benefits to each participating executive in the event of a termination of employment by the Company without Cause (as defined in the Severance Plan) or due to the executive’s voluntary resignation for Good Reason (as defined in the Severance Plan). The Severance Plan defines each event as a “Qualifying Separation from Service.” In the event of a Qualifying Separation from Service, subject to the executive’s execution of a general release of liability in favor of the Company and compliance with the terms of any restrictive covenant agreement for two years following the Qualifying Separation from Service, the Severance Plan provides for the following payments and benefits:
a severance payment (paid over an 18-month period) calculated as base salary multiplied by one- and one-half in the case of the Chief Executive Officer, Chief Financial Officer, the President of The Baldwin Group and CEO of Retail Brokerage Operations, and the President of The Baldwin Group and CEO of Underwriting, Capacity & Technology Operations (collectively, the “Group 1 Executives”) or a severance payment (paid over a 12-month period) calculated as base salary multiplied by one in the case of the Chief Accounting Officer, General Counsel, Chief Colleague Officer, Chief Marketing Officer, and Chief Digital and Information Officer of the Company (collectively, the “Group 2 Executives”);
payment of any earned but unpaid bonus under the Company’s AIP for the completed prior year if the Qualifying Separation from Service occurs prior to the scheduled date of the payment for such bonus;
a portion of the executive’s AIP payment for the year in which the Qualifying Separation from Service occurs, determined in accordance with the applicable criteria (assuming the “Target” threshold was achieved) under the AIP and pro-rated for the time in the executive’s role for such year;
continued vesting of time-based equity awards under the Company’s Omnibus Incentive Plan; and
payment of the executive’s premiums under the Consolidated Budget Reconciliation Act of 1985, as amended from time to time (“COBRA”) for a period of up to 12 months following the Qualifying Separation from Service.
Changes in Control
The Severance Plan also provides for the payment of enhanced severance and other benefits to executives in the event of a Change in Control during the Protected Period (as defined in the Severance Plan). In the event of a Change in Control not involving a Qualifying Separation from Service within the period beginning 90 days before the Change in Control and ending on the date 12 months following the Change in Control (the “Change in Control Period”), the Severance Plan provides the following payments and benefits to the executives:
continued participation in the applicable bonus program pursuant to the Company’s AIP or bonus provided by the executive’s employment agreement in the event the AIP or such employment agreement is assumed by the acquiror, or payment of a pro-rated bonus (assuming the “Target” threshold was achieved) based on the portion of the current year in which the executive was employed by the Company prior to the Change in Control in the event the AIP or employment agreement is not assumed by the acquiror; and
48


continued vesting of time-based and performance-based equity awards under the Company’s Omnibus Incentive Plan in the event the Company’s Omnibus Incentive Plan is assumed by the acquiror or accelerated vesting of time-based and performance-based equity awards under the Company’s Omnibus Incentive Plan in the event the Company’s Omnibus Incentive Plan is not assumed by the acquiror (with such acceleration effective as of date of the Change in Control with any applicable performance-based vesting determined in good faith by the Compensation Committee upon such Change in Control, treating the effective date of such Change in Control as the last day of the applicable performance period).
In the event of a Qualifying Separation from Service during the Change in Control Period, and subject to the executive’s execution of a general release of liability in favor of the Company and compliance with the terms of any restrictive covenant agreement for two years following the Qualifying Separation from Service, the Severance Plan provides the following payments and benefits to the executives:
a severance payment (paid over a 24-month period) calculated as base salary multiplied by two in the case of the Group 1 Executives or a severance payment (paid over a 12-month period) calculated as base salary multiplied by one in the case of the Group 2 Executives;
payment of any earned but unpaid bonus under the Company’s AIP for the completed prior year if the Qualifying Separation from Service occurs prior to the scheduled date of the payment for such bonus;
a portion of the executive’s AIP payment for the year in which the Qualifying Separation from Service occurs, determined in accordance with the applicable criteria under the AIP (assuming the “Target” threshold was achieved) and pro-rated for the time in the executive’s role for such year;
accelerated vesting of time-based and performance-based equity awards under the Company’s Omnibus Incentive Plan (with such acceleration effective as of the date of the Qualifying Separation from Service with any applicable performance-based vesting determined in good faith by the Compensation Committee upon such Change in Control, treating the effective date of such Change in Control as the last day of the applicable performance period); and
payment of the executive’s COBRA premiums for a period of up to twelve months following the Qualifying Separation from Service.
The above description is a summary of the terms of the Severance Plan and is subject to, and qualified in its entirety by, the terms of the Severance Plan, a copy of which is included in this report as Exhibit 10.1 and incorporated herein by reference.
49


ITEM 6. EXHIBITS
The following exhibits are filed as a part of this Quarterly Report on Form 10-Q:
Exhibit No.Description of Exhibit
3.1
3.2
3.3
3.4
3.5
10.1*
10.2*
31.1*
31.2*
32**
101.INS*
XBRL Instance Document
101.SCH*
XBRL Taxonomy Extension Schema Document
101.CAL*
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
XBRL Taxonomy Extension Label Linkbase Document
101.PRE*
XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted in inline XBRL and included in Exhibit 101)
__________
*    Filed herewith
**    Furnished herewith and as such are deemed not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
50


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
The Baldwin Insurance Group, Inc.
Date: November 4, 2024By:/s/ Trevor L. Baldwin
  Trevor L. Baldwin
  
Chief Executive Officer
   
Date: November 4, 2024By:/s/ Bradford L. Hale
  Bradford L. Hale
  
Chief Financial Officer

51